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ABSTRACT  
 
 
 There is an epidemic of sexually transmitted diseases (STDs) in the United States. 
Populations most affected by STDs are young adults, particularly those living in a high risk 
environment such as a college or university. African American’s are disproportionately at risk 
for STD’s. One of the most prevalent STD’s on college campuses today is the Human 
Papillomavirus (HPV). Genital HPV is a sexually transmitted disease which is primarily known 
for causing genital warts and cervical cancer. In 2007, the first vaccine to prevent HPV was 
approved. The purpose of this study was to investigate the contributing factors for HPV vaccine 
acceptance among African American young adults.  The Health Belief Model (HBM) served as 
the theoretical framework to guide this study. Findings revealed that among African American 
young adults, perceived susceptibility to HPV, perceived benefits of HPV and perceived barriers 
to HPV vaccination were found to be significant factors for HPV vaccination intention. Findings 
further reveal a significant difference in knowledge of HPV between men and women, with 
women showing higher knowledge scores. Additionally, African American young adults with 
higher traditional masculinity ideology were less likely to accept the HPV vaccine. Findings add 
to the current state of the science regarding HPV knowledge and contributing factors for HPV 
vaccine acceptance among African American young adults. 
 
 
vii 
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CHAPTER 1: INTRODUCTION 
 Sexually transmitted disease (STD) is a term used to describe more than 20 
different infections that are transmitted through the exchange of semen, blood, and other 
body fluids; or by direct contact with the affected body areas of people with STDs 
(Haggerty, 2002). They are caused by infections that are passed from one person to 
another during sexual contact. These infections often do not cause any symptoms. 
Medically, infections are only called diseases when they cause symptoms. That is why 
STDs are also called “sexually transmitted infections (STI).” However, it is common for 
people to use the terms “sexually transmitted diseases” or “STDs” even when there are no 
signs of disease (Sexually Transmitted Diseases [STDs], 2009). Some STDs can be 
prevented by abstaining from sexual contact, while others can be prevented with vaccine. 
All communities are impacted by sexually transmitted diseases; as individuals 
coping with the physical, emotional and financial burden of the disease, as care providers 
in communities who deal with the economic costs of the disease, as social workers who 
provide counseling and education to those affected by STD’s. The Centers for Disease 
Control and Prevention (CDC) have reported that 85% of the most prevalent infectious 
diseases in the United States are sexually transmitted (Haggerty, 2006). The CDC reports 
that STDs cost the U.S. health care system $17 billion dollars every year (STD Trends in 
the United States, 2012). The cost to individuals is even higher with immediate and life-
long health consequences. The rate of STDs in this country is 50 to 100 times higher than 
that of any other industrialized nation. Furthermore, about 19 million new sexually 
transmitted infections occur in the United States each year with one in four sexually 
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active Americans affected by an STD at some time in his or her life (Centers for Disease 
Control and Prevention, 2010). Populations most at risk for STI’s are young adults 
(“Advocates for Youth”, 2012).  
Several theorists developed models and stages of human growth and 
development. Each of these theorists defines the age range of young adulthood 
differently. One such theorist, Erik Erikson, developed an eight stage theory of 
development (Erikson, 1950). Erikson focused on adolescence as one of the 
transformative periods in development. However, he noted that increased trajectories for 
marriage and career choices  in industrialized society  is leading to a “prolonged 
adolescence” period of development (Erikson, 1968). From a biological perspective, 
adolescents are maturing at an earlier age. Hines (1999) observed that physically, 
adolescents become adults at a younger age, yet do not have the cognitive capabilities to 
cope with a complex social environment as adults. Furthermore, Hines suggests that the 
resulted tension may contribute to issues such as unprotected sexual behavior, which has 
biological as well as social etiology. 
Today, in the 21st century, theorists are creating a new field of interest describing 
the development of adolescents into adulthood. Arnett (2010) describes what Erickson 
referred to as “prolonged adolescents” as the current concept of “emerging adulthood”. 
Emerging adulthood is a period in one’s life marked by physical, emotional and sexual 
development. Arnett presents tenants of emerging adulthood as being related to the birth 
control pill and less stringent standards of sexual morality, which has enabled women to 
prolong marriage and childbirth. Young adults are now engaging in a series of sexual 
relationships prior to or without marriage. A second tenant of emerging adulthood is the 
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increase in years devoted to higher education. A higher proportion of young adults are 
entering college now more than at any other time in American history (Arnett, 2012). 
Most recently, the Young Adult Development Project found that across theories 
and research frameworks, a sequence of developmental shifts emerged into three overall 
categories; 1) adolescence (puberty through age 18), young adulthood (18-25) and 3) 
later adulthood (mid-20’s and older) ("Young Adult," 2008). It is during this 
developmental period when teens thinking capacities, relationship skills, and ability to 
regulate emotions are unlikely to be at a level where they can easily cope with a diverse 
and rapidly changing world (“Young Adult,” 2008). The hope is that biology and 
environment will bring about a surge of growth paralleling those of childhood and 
adolescence. One particular tenant in this developmental period is that young adults have 
an easier time modulating risk-taking behavior and making decisions about the future, 
such as those involving health and relationships.  
A disproportionate number of today’s young adult women and men engage in 
unsafe sexual practices that enhance the risks of sexually transmitted diseases ((Davidson 
& Lawrence, 2004). Estimates suggest that even though young people aged 15-24 years 
represent only 25% of the sexually experienced population, they acquire nearly half of all 
the 19 million new STDs that occur each year (“STD surveillance,” 2010). African 
American women, particularly those attending college, belong to a population that has 
some of the highest rates of sexually transmitted infections (Thomas & Freeman, 2011). 
For college students in particular, it is a time in their lives when they are encouraged to 
explore new and different experiences. For many young people, it is the first time in their 
lives when they are on their own and away from the watchful eye of a parent or guardian. 
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The college environment lends itself to behaviors that may result in negative outcomes, 
such as drinking alcohol, smoking cigarettes, engaging in sexual activity, and practicing 
risky sexual behaviors. In a study of African American college freshman, St. Rose (2008) 
found that 48.4% (n=94) of the respondents indicated that they had vaginal sex both with 
and without a condom and the median number of asexual partners was 2.5, with a range 
of 1-5 (p.4). The behaviors described are often experienced for the first time on the 
college campuses around the United States. Studies conducted on college campuses have 
found that at least 70% of young adults are sexually active (American College Health 
Association [ACHA], 2007). A particular concern with this population is the STD of the 
human papillomavirus (HPV). HPV is the most common STD on college campuses today 
(CDC, 2012). 
Human Papillomavirus (HPV)  
Physicians are only required to report to local or state public health authorities the 
STD incidence rates of gonorrhea, chlamydia and syphilis. However, these STDs only 
capture a fraction of the incidence of all STDs while excluding others, such as genital 
herpes and the human papillomavirus (CDC, 2010). Genital HPV is primarily known for 
causing genital warts and is the most common sexually transmitted infection in the 
United States (Intlekofer, Cunningham, & Caplan, 2012). Approximately 20 million 
Americans are currently infected, and about 6.2 million more get infected each year 
(CDC, 2010). The highest rates are seen among women between the ages of 20-24, with a 
prevalence rate of 45% ("MMWR sexual health," 2009).  Additionally, these statistics are 
underrepresented due to the fact that they are not always reported; HPV is asymptomatic 
and often clears on its own. 
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HPV is a large category of at least 120 double-stranded DNA viruses (Intlekofer, 
Cunningham, & Caplan, 2012). There are more than 40-HPV types that can infect the 
genital areas of males and females. These HPV types can also infect the mouth and throat 
(CDC, 2013). The CDC estimates close to 5.5 million new genital HPV cases occur each 
year. Most people who become infected with HPV do not even know they have this 
infection. HPV is not the same as herpes or the Human Immunodeficiency Virus (HIV is 
the virus that causes Acquired Immune Deficiency Syndrome [AIDS]). These are all 
viruses that can be passed during sexual contact, but they cause different symptoms and 
health problems. Most people with HPV do not develop symptoms or health problems 
from it, and in 90% of cases, the body’s immune system clears HPV naturally within two 
years. Sometimes, certain types of HPV can cause genital warts in males and females. 
Approximately 90 percent of genital wart infections are caused specifically by HPV types 
6 and 11 (Intlekofer et al., 2012).   
Of the 40 HPV types that infect the genital area, causing genital warts, there are 
some types that may also cause cervical intraepithelial neoplasia (CIN) (CDC, 2013), a 
condition of abnormal growth that can progress to cervical cancer (Intlekofer et al., 
2012). Ninety percent of CIN cases are associated with HPV infection (Walboomers, 
Jacobs, & Manos, 1999). Of these, the high risk types of 16 and 18 together account for 
more than 74 percent of all cervical cancer and other cancers in both men and women 
including anal, penile and oral cancer. Compared to types 6 and 11, these high risk types 
show a delay in clearance. College-age African-American women, in particular, have a 
more difficult time clearing human papillomavirus infection and are more likely to have 
an abnormal Pap test than European-American women ("HPV Infection Lasts Longer," 
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2013). In the Carolina Women’s Care Study, Creek found that 56 percent of African-
American women were shown to be infected two years after the initial infection 
compared to 24 percent of European-American women (Creek, 2012). Among the types 
of HPV that can cause genital warts, types 6 and 11 are not the same as the types that 
may cause cancer, types 16 and 18. However, there is no way to know or detect which 
people who get HPV will go on to develop HPV related cancer or other health problems 
(CDC, 2009). 
Cervical cancer is almost always caused by the human papillomavirus infection 
(CDC, 1999). The CDC (2007) states that approximately 10 of the 40 identified genital 
HPV types can lead to development of cervical cancer. HPV types 16 and 18 cause about 
70 percent of cervical cancers (Munoz et al., 2004).The American Cancer Society (ACS) 
estimated that in 2009, 11,270 women were diagnosed with invasive cervical cancer in 
the United States, and 4,070 women would succumb to the diseases. African-American 
women develop this invasive cervical cancer about 50% more often than non-Hispanic 
White women. Furthermore, African American women are more than twice as likely to 
die from cervical cancer as White women (ACS, 2008).  The ACS Guidelines (2007) 
state that significant racial and ethnic disparities exist with regard to incidence, mortality, 
and survival associated with the diagnosis of cervical cancer in this country. Cervical 
cancer incidence is approximately 60% higher among African American women (10.5 
cases per 100,000 persons) compared with White women (6.6 cases per 100,000 persons), 
and cervical cancer mortality among Black women is the highest (4.7 cases per 100,000 
persons) of any racial or ethnic group. 
The human papillomavirus is contracted most often through unsafe sexual  
 7 
 
 
practices ("National Cervical Cancer Coalition," 2007). Despite years of widespread  
 
proliferation of informational materials, there has been little change overall in young  
 
adult’s risk-taking behavior (CDC, 2009). Risky sex behaviors have been documented in  
 
the literature and include oral, vaginal or anal sexual contact without a condom, sexual  
 
intercourse without birth control or using birth control inconsistently, having sexual  
 
intercourse with multiple partners, and alcohol use . Over the last few years there has  
 
been a trend in the sexual risk taking behavior of young adults. Today, we hear the terms  
 
such as; “hooking up”, “friends with benefits” and “casual sex”.  Daniel and Fogarty  
 
(2007) describe these terms as depicting a downward trend in traditional forms of dating.  
 
These terms refer to casual sexual interactions, which have become an alternative to  
 
exclusive sexual relationships. These relationships are often short-lived, nonexclusive  
 
and emotionally shallow, with a purpose of one-time sexual activity (Glenn & Marquardt,  
 
2001). In a recent study on “hook-ups” with college women, condom use was reported  
 
for 0% of oral sex hookups and only 69% of vaginal sex hookups (Fielder & Carey,  
 
2010). In a qualitative study, Downing-Matibag and Geisinger (2009) found that college  
 
students misperceive their vulnerability to STIs when engaging in a “hook-up”. In their  
 
study, they found that of the 71 participants, not one reported that they used protective  
 
barriers against STIs when giving or receiving oral sex (p. 1200). Young adults’ failure to  
 
adopt safer practices, such as the consistent use of condoms or dental dams, may be  
 
related to differences in how they perceive risk that are not immediately personally  
 
relevant.  
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STDs affect people of all races, ages, and sexual orientations, though some  
 
individuals experience greater challenges in protecting their health. Race and ethnicity  
 
are not risk factors but are risk markers that correlate with fundamental determinants of  
 
health, such as poverty and limited access to quality health care ("Race and Risk," 2011). 
 
 STDs take an especially heavy toll on African Americans, particularly young African  
 
American women and men. African Americans are disproportionately at risk for  
 
infections such as chlamydia, gonorrhea, herpes, and syphilis. African Americans make  
 
up just 13 percent of the U.S. population, yet in 2009 accounted for approximately half of  
 
all new cases of chlamydia and syphilis (48 percent and 52 percent respectively), and  
 
some 71 percent of gonorrhea cases. Additionally, African Americans also experienced  
 
more than half of newly diagnosed HIV infections (Cullins, 2011). The HPV Sentinel  
 
Surveillance Project was carried out from 2003 to 2005 and found that in 26  
 
geographically diverse clinics, an estimated 25% of African  Americans were infected  
 
with high risk HPV types (Datta, Koutsky, & Ratelle, 2008). 
 
Those that live in communities with high rates of STDs are at greater risk for 
being exposed to an STD during sexual intercourse. In Missouri, sexually transmitted 
diseases have been increasing at an alarming rate. In a 2010 STD profile, the CDC ranked 
Missouri 16th highest among 50 states in chlamydial infections (422.2 per 100,000 
persons) and ranked 14th in gonorrheal infections (136.3 per 100,000 persons) (CDC, 
2012). A report by the CDC (2009) noted half of Missouri teenagers are sexually active, 
and estimates that 50 percent of them will contract an STD by the age of 25. Many of 
these young adults will be unaware of having an infection and will unknowingly infect 
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their partner. In communities where STD prevalence is higher, individuals may have a 
more difficult time reducing their risk for infection (“STD surveillance,” 2010).  
HPV is one of those STDs that can remain asymptomatic (without symptoms); 
however, an infected person can still transmit the disease through sexual contact.  HPV 
infections can be subclinical or asymptomatic. Subclinical HPV infection is detected by 
abnormal Pap smears or microscopic lesions. Asymptomatic HPV infection is the 
presence of the virus in apparently normal tissue. Most people are unknowingly infected 
with asymptomatic HPV and are therefore at a greater risk for transmitting the infection 
to their sexual partner(s). Furthermore, HPV can lie dormant on the cervix for up to 20 
years before a cervical cancer, such as cervical dysplasia (precancerous cells) is detected 
(Koutsky, 1997). Because STD prevalence is already higher in African American 
communities than in others, even the individual in this community who has only one sex 
partner can be at increased risk of infection. To date, there is no cure for HPV; therefore, 
one of our best defenses is through prevention by way of the HPV vaccination.  
HPV Vaccines 
Gardasil®. In June of 2006, the Food and Drug Administration (FDA) licensed 
the first HPV vaccine. Merck Pharmaceuticals introduced the HPV vaccine, Gardasil®, 
to prevent genital warts, cervical cancer and HPV related diseases in young women. 
Subsequently, in October, 2009, Merck introduced the HPV vaccine for young men 
between 11-26 years of age. Gardasil® is a quadrivalent Human Papillomavirus 
recombinant vaccine. This HPV vaccine will protect men from genital warts and HPV-
related cancers such as anal cancer. Gardasil® is called a quadrivalent vaccine because it 
 10 
 
protects against four types of infections associated with types 6, 11, 16, and 18. 
("Gardasil® HPV vaccine," 2007).   
Cervarix®. In October, 2009, the FDA licensed Cervarix®, the second HPV 
vaccine to help prevent cervical cancer in women. Cervarix® is a bivalent vaccine. 
Cervarix® is called a bivalent vaccine because it protects against the types of infections 
associated with types 16 and 18. It helps prevent cervical cancer and precancers 
associated with these HPV types. Cervarix® is approved for girls and young women 
between the ages of ten and twenty five ("Cervarix® HPV vaccine," 2009).  
 The CDC’s Advisory Committee on Immunization Practices (ACIP) sets the 
guidelines on when immunizations should be given. In October of 2011, the ACIP 
recommended that the HPV vaccine be given to boys and girls at 11 and 12 years of age. 
Beyond this age, the ACIP recommends young men and women up to age 26 receive it as 
a “catch-up” vaccination (Morbidity and Mortality Weekly Report, 2011). However, a 
health care provider, at his or her discretion, may administer the vaccine to a boy or girl 
at the age of 9 ("HPV vaccine," 2011). Both HPV vaccines are given in three injections 
over a six month time period (0, 2 months, and 6 months). It is necessary to receive all 
three doses to reap the full benefit of the vaccine. It is suggested that the HPV vaccine be 
given prior to one becoming sexually active. However, if a person has not been infected 
with HPV at the time of vaccination, they will still be fully covered by the vaccine. Even 
if a person has been infected with one type, they would still get the benefit of protection 
from the other HPV vaccine types through vaccination. Because these are relatively new 
HPV vaccines, their immunity length is unknown. The research continues, however, and 
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studies with six years of follow-up data show that there is no evidence that the protection 
loses effectiveness (CDC, 2012).  
Although Gardasil® has been heavily promoted for young women through the 
media via captivating commercials such as the “One Less” slogan and the "Tell 
Someone" campaign, Gardasil® for young men has yet to be widely advertised to the 
general public. Furthermore, the advertisements that both young women and men see on 
television and in magazines fail to impart the importance of issues such as; practicing 
safer sex methods, the causal relationship between HPV and cancers with both men and 
women, how HPV affects young men, or the transient nature of HPV between young men 
and women. What is often misunderstood is that men are carriers of the HPV virus and 
therefore, can transmit HPV to a sexual partner. An issue with men who are infected with 
HPV is the potential to infect women, which may lead to substantial morbidity and 
mortality of infected women (Palefsky, 2010). 
Contributing Factors of HPV Vaccine Acceptance 
Knowledge 
Although knowledge is not a direct predictor of health behavior, health behavior 
theories hypothesize that it is a distal factor mediated by attitudes, risk perceptions, social 
influence, and self efficacy. Thus, acquiring knowledge is a key first step to the success 
of any health education intervention (Tiro, Meissner, Kobrin, & Chollete, 2007). One’s 
knowledge level regarding HPV, the negative HPV-related health outcomes and the HPV 
vaccine may influence ones decision to receive the vaccination. Therefore, it is 
imperative to assess the current knowledge level of HPV and the HPV vaccine with 
African American young adults. 
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Health Belief Model  
The Health Belief Model (HBM) has been used for decades to explain and predict 
health behaviors (Rosenstock, 1974). The HBM is a theory that has successfully 
predicted a wide range of health behaviors, including STI vaccination (Gerend, Cruz Lee, 
& Shepherd, 2007).The HBM posits that a person’s intention to perform a given 
preventative behavior is influenced by one’s knowledge of a disease threat and one’s 
attitudes regarding that disease (Rosenstock, 1974). The theoretical framework of the 
HBM asserts that a person’s attitude regarding a particular disease, such as HPV, 
involves a) the individual’s perceived susceptibility to the disease, b) the perceived 
severity of the disease, c) the perceived benefits of performing the preventative behavior, 
d) the perceived barriers that may place constraints on performing the behavior, and e) a 
resilient sense of efficacy in overcoming obstacles through perseverant effort.  Social 
psychological and demographic variables such as; gender, race and education level, may 
affect the individual’s perceptions and therefore, indirectly influence particular health-
related behaviors (Rosenstock, 1974).  
To date, the literature measuring the constructs of the Health Belief Model in 
relation to HPV has been limited in scope and application. Three studies asked questions 
regarding perceived susceptibility to HPV and perceived severity to HPV (Lopez & 
McMahan, 2007; McPartland, Weaver, Lee, & Koutsky, 2005). Additionally, the HBM 
has been utilized to examine the perceived benefits and barriers to vaccine acceptance 
(Caskey, 2009; Gerend, Lee & Shepherd (2007). The HBM has also been used as a 
framework for HPV studies that included African American young adults (Gerend, Lee, 
& Shepherd, 2007; Gerend & Magloire, 2008; Gerend & Barley, 2009). However, the 
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percentage of African American representation within those samples has been very small. 
Given a larger sample of African American young adults, the HBM may provide a useful 
theoretical framework for understanding the sexual health behaviors, HPV knowledge 
and HPV vaccine acceptance with this population.  
Masculinity Ideology 
Masculinity ideologies are belief systems about what it means to be a man, and 
the degree to which a man endorses and internalizes his cultures values and norms about 
masculinity (Addis & Mahalik, 2003). Traditional masculinity ideology serves to uphold 
patriarchal codes by requiring that males adopt dominant and aggressive behaviors and 
function in the public sphere, while requiring that females adopt adaptive and nurturing 
behaviors and function in the private sphere of the family (Levant, 1997). Masculinity is 
often expressed by men through the mainstream and traditional ideals of accumulating 
wealth and material possessions and by gaining social power and positions of influence 
(Oliver, 1988). In a 1995 study, Harris suggested that traditionally, White masculine 
ideals are often unattainable for African American men due to “material constraints” of 
race.  Harris states that the pressures to meet European American standards of manhood 
as provider, protector, and disciplinarian are representative of such a dilemma for African 
American men. Inequities in earning potential and employment and limited access to 
educational opportunities prevent the expression of these behaviors (p.279-280). African 
American men often lack the power and resources necessary to express masculinity in 
this regard. Instead, they often typically rely on alternative modes of masculine 
expression (Harris, 1995). In turn, these perceptions and experiences force them to find 
alternative ways to prove their manliness. For instance, Oliver (1989) described a primary 
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orientation through which masculinities are expressed by African American men, the 
"player of women." Players are young men who have established reputations for having 
many girlfriends and engaging in sexual relations with multiple women.   
Traditional health models, like the HBM, are problematic because they do not 
adequately incorporate the importance of a masculine identity to health (Duck, 1995). 
Duck states that according to the Health Belief Model, men who perceive a personal 
threat to their health and believe that a health practice will reduce that threat are more 
likely to engage in health practices to reduce the threat. Focus group findings from a 
qualitative study reported that African American men knew that certain health behaviors 
were risky, and recognized how to reduce those risks (e.g., going to the physician for 
screening), or the consequences of a particularly risky behavior. Yet those men continued 
to be engaged in risky sexual behaviors to express ambivalence about going to the 
physician, even though they knew the risk associated with their behavior (Duck, 2009).   
Statement of the problem 
Racial and ethnic minorities, particularly African Americans, continue to be 
disproportionately affected by STDs in the United States. Data from the CDC’s 2006 
STD Surveillance Report show higher rates of all STDs among minority racial and ethnic 
population when compared to Whites, with the exception of Asians/Pacific Islanders 
(CDC, 2007). The Human Papillomavirus is an STD that has negative health-related 
outcomes and has the potential to lead to HPV-related cancers in African American 
young adults. To date, Gardasil® and Cervarix® are the only HPV vaccines approved by 
the FDA for young women and men. There is paucity in the literature related to HPV and 
HPV vaccine acceptance among African American young adults, specifically in the state 
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of Missouri. Having a better understanding of the HPV related knowledge level and 
contributing factors that affect HPV vaccine acceptance will advance social workers and 
health professionals’ ability to better serve African American young adults with HPV and 
HPV vaccination inquiries, aid in HPV educational interventions and will contribute to 
informed vaccination decision making.  
Statement of purpose 
As educators, clinicians and researchers, social workers must strive to understand 
what factors contribute to African American young adults to seek information and engage 
in preventive health practices related to HPV, such as the HPV vaccination. Currently, 
there is a dearth of literature regarding HPV and HPV vaccine acceptance among African 
American young adults, especially men. To date, there have been minimal investigations 
of African American young adults’ knowledge, and the contributing factors associated 
with HPV and HPV vaccine acceptance. The current study is one of the first to examine 
this area of interest since the October 2009 FDA approved the use of Gardasil® for 
young men. In addition, African American masculinity ideology, in relation to young 
adults’ sexual health behaviors has received very limited examination (Levant & Majors, 
1997). The purpose of this study was to apply the constructs of the Health Belief Model 
to examine African American young adults’ HPV knowledge, health belief factors (e.g., 
perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and 
self-efficacy) and masculinity ideology regarding HPV vaccine acceptance. 
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Research Questions  
1) Is there a relationship between knowledge, contributing factors within the Health 
 Belief  Model (perceived susceptibility, perceived seriousness, perceived benefits, 
 perceived barriers, and self-efficacy)  and one’s acceptance of the HPV vaccine 
 among African American young adults? 
2) Is there a gender difference related to knowledge, contributing factors within the 
Health Belief Model (perceived susceptibility, perceived seriousness, perceived 
benefits, perceived barriers, and self-efficacy) and one’s acceptance of the HPV 
vaccine among African American young adults? 
3) Is there an educational level (freshman/sophomore and junior/senior) difference  
related to knowledge, contributing factors within the Health Belief Model 
(perceived susceptibility to HPV, perceived seriousness of HPV, perceived 
benefits of vaccination, perceived barriers to vaccination, and self-efficacy) and 
one’s acceptance of the HPV vaccine among African American young adults? 
4) Is there a relationship between traditional masculinity ideology and intention to receive 
 the HPV vaccine. 
Hypotheses  
1) Greater knowledge about HPV, higher perceived susceptibility to HPV, higher 
 perceived  seriousness of HPV, greater perceived benefits of the HPV vaccine, 
 and greater self-efficacy will increase the likelihood of being willing to get the 
 HPV vaccine, while greater perceived barriers will reduce HPV vaccine 
 acceptance among African American young adults. 
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2) African American young women will have more knowledge about HPV, perceive their 
susceptibility to HPV as higher, perceive the seriousness of HPV to be higher, 
perceive greater benefits of the HPV vaccine, have greater self-efficacy, perceive 
fewer barriers to vaccination, and be more likely to accept HPV vaccination, 
compared to African American young men. 
3) Is there an educational level (freshman/sophomore and junior/senior) difference related 
to knowledge, contributing factors within the Health Belief Model (perceived 
susceptibility, perceived seriousness, perceived benefits, perceived barriers, and 
self-efficacy) and one’s acceptance of the HPV vaccine among African American 
young adults. 
4) African American young adults with higher traditional masculinity ideology will be 
 less likely to accept HPV vaccination. 
Delimitations, Limitations and Assumptions 
The sample populations were recruited from African American men and women 
who were enrolled at one of ten public colleges or universities in the state of Missouri 
during the study time period of June 2010 through March 2012 (Fall and Spring 
semesters). The participants were between the ages of 18 and 26, which correspond with 
the Gardasil® and Cervarix® vaccination age requirements. The study utilized a 
convenience sampling methodology and self-selection bias of study participants may 
have occurred. This descriptive research study cannot be generalized to all African 
American young adults, particularly those who have not attended a public college or 
university in Missouri. It was assumed that the participant had a certain level of literacy, 
reading comprehension and basic computer skills in order to respond to the online survey 
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questions. It was further assumed that participants reported truthful and accurate 
responses, as the survey relied on self-reported information. 
Definition of Terms 
List of terms defined for the purposes of this research study: 
Young adult: Male or female between the ages of 18-26. 
African American: A self-described male or female of American African descent. 
Human Papillomavirus (HPV): Genital HPV infection is a sexually transmitted disease 
that is caused by human papillomavirus. HPV is the name of a group of viruses that 
includes more than 100 different strains or types (CDC, 2008).  
HPV Vaccine: A vaccination series approved by the FDA for 9-26 year old women and 
men that guard against the spread of HPV (CDC, 2007; 2009). 
Perceived barriers: One’s perception regarding the potential negative consequences that 
may result taking particular health actions, including physical, psychological and 
financial demands (Rosenstock et al., 1994). 
Perceived benefits: The degree to which an individual believes that taking a specific 
action to prevent a condition will be beneficial and effective (Bandura, 1986). 
Perceived severity: One’s perception concerning the seriousness of contracting an illness, 
or leaving it untreated; include evaluations of medical, clinical, and social consequences 
(Rosenstock et al., 1994). 
Self-efficacy: The belief in being able to successfully execute the behavior required to 
produce the desired outcome, such as HPV vaccination (This concept was introduced by 
Bandura in 1977). Self-efficacy behaviors related to HPV vaccination may include 
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obtaining information about the vaccine and making a clinical appointment to discuss the 
vaccine. 
Vaccine acceptance: One’s willingness or intent to obtain the HPV vaccination: 
Gardasil® and Cervarix® are vaccination series approved by the FDA for 9-26 year old 
females (CDC, 2007) and 9-26 year old males (CDC, 2009). 
Significance 
 One of the aims of Healthy People 2010 was to reduce the proportion of females 
with Human Papillomavirus (HPV) infection ("Health People 2010," 2000). In this effort, 
it was necessary to gain an understanding of current knowledge within the African 
American population in regards to HPV and HPV vaccine knowledge as well as HPV 
vaccine uptake. The current research study will contribute to the state of the science 
related to the Human Papillomavirus awareness and knowledge as well as HPV vaccine 
acceptance with African American young adults. Findings from this study may heighten 
awareness of sexual health behaviors, the virus itself, transmission, and negative health 
outcomes associated with HPV within the African American community. Most 
importantly it focused on African American young adults who are disproportionately 
affected by sexually transmitted diseases and the negative health outcomes related to 
HPV.  
Health care professionals, such as social workers, nurses and clinicians who work 
in healthcare environments and academic settings are in ideal positions to communicate 
the facts about the prevalence of HPV, transmission issues, the HPV vaccine, and the 
psychosocial concerns surrounding HPV. Findings from this study may help social 
workers, health care providers and community health workers to provide relevant health 
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information and educational interventions to help improve the sexual health of African 
American young adults. With the recent approval of the HPV vaccine for young men, it is 
imperative to include gender, issues of transmission, culturally appropriate educational 
interventions and social marketing efforts in regards to vaccine acceptance initiatives. 
Ultimately, this study provides new knowledge regarding the contributing factors that 
may influence HPV vaccine acceptance among African American young adults attending 
a public college or university in the State of Missouri.  
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CHAPTER 2: LITERATURE REVIEW 
This chapter reviews the empirical literature related to the contributing factors of 
HPV vaccine acceptance among African American young adults. The objective of the 
review was to examine research conducted on the human papillomavirus, HPV awareness 
and knowledge, knowledge regarding HPV-related cancer, HPV vaccine, HPV vaccine 
acceptance, sexual health behaviors and HPV, the Health Belief Model, and Masculinity 
Ideology in relation to African American young adults. 
Human Papillomavirus 
 One of the most prevalent STDs is the human papillomavirus; HPV is the name of 
a group of viruses that includes more than 100 different strains or types. The FDA (2008) 
states that both men and women carry the human papillomavirus and epidemiologic 
studies further suggest that 75% of all people who are sexually active will become 
infected with HPV at some point in their lives (Koutsky, 1997). Of these types, 
approximately 40 exist in the genital area and can cause genital warts. These 40 strains 
can be further broken down to “high” and “low” risk strains. HPV types are often referred 
to as “low-risk” (wart-causing) or “high-risk” (cancer-causing), based on whether they  
place a person at risk for cancer ("HPV types," n.d.). Low-risk strains sometimes cause 
changes in a Pap smear (a test used to look for changes in the cells of the cervix) but do 
not progress to cancer. Of the low-risk strains, two types (6 and 11) are most likely to 
cause genital warts. There are approximately 13 high-risk strains of HPV, of which two 
types (16 and 18), are believed to cause about 74% of all cervical and HPV related 
cancers (Munoz, Bosch, & Castellsague, 2001). 
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 The following is a review of the empirical literature on young adults’ knowledge 
of HPV, HPV vaccine acceptance, HPV-related cancer, the Health Belief Model, and 
Masculinity Ideology. Research studies conducted in the United States from1997-2009 
were included in the review. Most of the studies obtained samples from University 
settings. There were studies that included African American participants; however, the 
percentage of representation in general is very low.  There were two studies with a 
majority of African American respondents: D’Urso, Thompson-Robinson, and Chandler 
(2007), conducted a study at an Historically Black University (HBCU) and Gerend and 
Barley (2008), recruited from an HBCU with 57% African American participants. Of the 
20 studies in this review, 10 were conducted with women only, 5 included men and 
women participants, and 5 included all male participants. Seventeen studies utilized a 
quantitative methodology, with three studies using a qualitative method of inquiry.  
Human Papillomavirus Awareness and Knowledge 
 Knowledge about HPV infection. Awareness and knowledge about HPV 
infection varies widely and is impacted by the specific questions asked within each study. 
In studies where the participants were young women, there were varying degrees of 
participants’ knowledge about the term HPV. In another study, female nursing students’ 
knowledge of HPV was assessed ((Denny-Smith, Bairan, & Page, 2006)). The 
researchers in this study were surprised to find that the participating female students 
demonstrated relatively low knowledge levels for what one would expect for nursing 
students in their junior and senior years of college. The mean knowledge score was 10.2 
(range 1-15; SD = 2.4). In a different study of 172 college students attending personal 
health classes, 21.5% had never heard of HPV (Lopez & McMahan.). In a similar study 
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of students knowledge (Caron, Kispert, & McGrath, 2008) conducted at a Northeastern 
university, 85% (n=293) had heard of HPV prior to the survey administration. In 
response to the 2005 Health Information National Trends Survey (HINTS), Tiro et al 
(2007) conducted a study that analyzed cross sectional data from 18-75 year olds 
(n=3,076). The HPV knowledge level of U.S. women was relatively low; only 40% of 
women (n=1,248) reported that they had heard of HPV. Another study asked the question 
to Latina mothers who have teenage daughters (Bair et al., 2008). Most of the Latina 
mothers (n=31, 78%) had not heard of HPV. In 2009 (Cates, Brewer, Fazekas, Mitchell, 
& Smith, 2009), racial differences in HPV knowledge were assessed among rural 
Southern women; out of 91 respondents, only 24% of Black women reported having 
heard of HPV compared to 57% (n=47) of White respondents. 
In four studies that included both women and men, the percentage that had heard 
of HPV ranged from 12-67%. Yacobi, Tennant, Ferrante, Pal, and Roetzheim (1999) 
conducted a study of Florida State University student’s knowledge and awareness of 
HPV. Students’ awareness of HPV was limited, only 38% of respondents had heard of 
HPV prior to the survey. In another study, college students’ knowledge of HPV was 
assessed utilizing a brief information-only educational intervention (Lambert, 2000). 
There were no significant difference in scores for HPV items between the men and 
women. Overall, only a minority of college students were familiar with HPV. In yet 
another cross-sectional, study self-administered questionnaires were administered at one 
university and two community practices. Results were similar to other studies in that 33% 
of the 289 respondents (47% male and 53% female) had never heard of HPV (Holcomb, 
Bailey, Crawford, & Ruffin, 2004). 
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Social work and public health researchers examined HPV-related knowledge of 
Black students attending a HBCU (D’Urso et al., 2007). Most respondents (64%’ n=234) 
had never heard of HPV prior to the survey. Furthermore, of the 36% (n= 126) who heard 
of HPV, 52% (n=66) reported knowledge of HPV. Awareness and knowledge about HPV 
in a racially diverse sample of young adults reported that 78% (n=97), of the participants,  
heard of HPV (Gerend, et al. 2008). A significantly larger proportion of women (94%) 
than men (63%) had heard of HPV. 
Four studies asked the question about HPV to only men (Allen, Fantasia, 
Fontenot, Flaherty, & Santana, 2009; Gerend & Barley 2009; Lopez, Tanjasiri, & 
McMahan, 2008; McPartland et al., 2005). One study utilized a qualitative method to 
obtain HPV infection information (Allen et al., 2009). The study included six focus 
groups with 18-22 year old male students (n=45) from a private University. Many men 
did not know that both men and women were susceptible to the disease and referred to 
HPV as a “woman’s disease”. Three cross-sectional studies were conducted to explore 
the knowledge of HPV infection on college-aged men. In a single study, about half of the 
participants (54.9%) had not heard of HPV before receiving the study recruitment letter 
(McPartland et al., 2005). A second study found that about one third (33.7%, n=100) of 
the men had never heard of HPV (Lopez et al., 2008). However, in the third study, 295 
men (85%, n=356) had heard of HPV prior to being invited to participate in the study 
(Gerend & Barley, 2009). Investigators concluded that the high percentage may have to 
do with the study being conducted at the same time Gardasil® was being heavily 
promoted in the media via television commercials. 
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Eight studies asked participants if they knew that HPV can be asymptomatic. 
Three studies found between 10%-85% knew that the HPV infection be asymptomatic. 
Nonetheless, Yacobi et al. (1999) noted most students in the study were not aware that 
HPV could be present without visible signs. However, 23% of respondents felt certain 
that they would know if they had HPV. Interestingly, when asked to choose from a list of 
symptoms that might be caused by HPV, more than two-thirds of respondents indicated 
they did not know symptoms of HPV. In a 2000 study, 58% (n = 29) of young women 
diagnosed with cervical dysplasia did not know that HPV could be asymptomatic 
(Gehardt, Pong, Kollar, Hillard, & Rosenthal). Additionally, 42% incorrectly believed 
that those with HPV experienced symptoms such as itching, stomach pain, and pain 
during intercourse. In a survey of college women (Lambert, 2000), 85% knew that HPV 
lacked symptoms prior to an educational intervention. Post intervention, 95% knew that 
HPV was asymptomatic. A 2005 study assessing men’s perceptions and knowledge of 
HPV reported that only 9.9% of the participants knew that most people with HPV 
infection do not have visible signs or symptoms; however, 89% knew that HPV could be 
transmitted to sex partners even in the absence of symptoms (McPartland et al., 2005). 
In a study at a HBCU, only 16% (n = 351) of the African American students in 
the study knew that HPV could be asymptomatic (D’Urso et al., 2007). A recent study of 
college women reported that 84.4% (n = 172) of the respondents knew that most people 
with genital HPV have no visible signs or symptoms (Lopez & McMahan, 2007). In a 
racially diverse group of college students, 77% (n = 97) of the respondents answered 
correctly, “False”, to the question “A person usually has symptoms when infected with 
HPV” (Gerend & Magloire, 2008). Interestingly, in a recent study of men and HPV, 79% 
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(n = 100) knew that they could transmit HPV when they were asymptomatic and that 
most people with HPV (75%) have no signs or symptoms (Lopez, Tanjasiri, & 
McMahan, 2008).  
Eight studies in this review asked respondents if they knew that HPV can cause 
genital warts.  In these studies, between 27-75% of the respondents knew that HPV can 
cause genital warts. Baer, Allen, & Braun (2000) found only 11.6% of the women and 
4.2% of men (p<.05) knew that HPV was the cause of genital warts. Additionally, Bair, 
Mays, Sturm, & Zimet (2008) noted only 15 (38%) of the 40 Latina mothers had heard of 
genital warts, and of those, 12 knew it was a STI. Gerend et al. (2008) noted 31% of the 
college student respondents were unfamiliar with the connection between HPV infection 
and genital warts. A study by Holcomb et al. (2004) reported that 28% of respondents 
reported “true” when asked if they knew that “warty growths” were a symptom of HPV, 
20% responded “false” and 32% responded “don’t know”. In 2007, Lopez & McMahan 
conducted a study assessing college women’s knowledge of HPV and genital warts, 55% 
knew that HPV can cause genital warts. Lopez et al. (2008) conducted a similar study 
with men and found that 44% knew that HPV caused genital warts. McPartland et al. 
(2005) found 41.5% correctly answered “false” to the statement “genital warts are caused 
by the herpes virus”. Finally, in a HPV awareness study, Yacobi et al. (1999) noted 64% 
of the student respondents were unsure if HPV caused genital warts. 
Ten studies in this review asked respondents knowledge of HPV being a sexually 
transmitted disease. Yacobi et al. (1999) asked respondents if they knew how HPV was 
transmitted. Most respondents (59%) indicated they did not know. In a study of college 
students, 82.6% of the men and 45.6% of women indicated that they did not know how 
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HPV was transmitted (Baer et al., 2000). A community based study with female 
respondents asked the same question (Holcomb et al., 2004) and found that a little more 
than 50% of all participants knew that HPV could be transmitted sexually. Unfortunately, 
the data in this study also demonstrated that the average person knew the correct response 
for less than half of the knowledge questions. In assessing perceptions and knowledge, 
89% of the men in the study knew that HPV could be transmitted to sex partners 
(McPartland et al., 2005). Only 36% of the students at a HBCU responded that they had 
heard of HPV; of those, 55% (n = 66) reported knowing what it was (D’Urso et al., 
2007). In a study utilizing HINTS data, 64% of the women respondents who had heard of 
HPV knew that HPV is a STI (Tiro et al., 2007). Of Latina mothers’ who were asked 
about HPV transmission, eight of the nine (out of 40) who had heard of HPV knew that 
HPV was sexually transmitted (Bair et al., 2008). Lopez and McMahan (2007) found that 
college women scored over 80% on questions having to do with transmission. Similarly, 
Gerend and Barley (2009) found that at baseline three-fourths of the men understood that 
they could unknowingly transmit an HPV infection to their partner.  
Knowledge about HPV-related cancer.  
Eight studies in this review surveyed participants’ knowledge of HPV as a risk 
factor for cervical cancer. The association between HPV and cervical cancer was known 
by between 16-89% of the respondents.  Baer et al. (2000) found 16 (15.5%) of the men 
and 35 (15.1%) of the women knew of the HPV association with cervical cancer. 
Lambert (2000) noted 53% of students’ knew that HPV caused cervical cancer, prior to 
the educational intervention, and 88% knew post-intervention. When asked if HPV is the 
virus that can cause cervical cancer, 39% answered “True”, 8% “False” and 51% “Don’t 
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Know” (Holcomb et al., 2004). McPartland et al. (2005) found 89% of the men answered 
“True” when asked if HPV can cause cervical cancer. In a study by Lopez and McMahan 
(2007), 91.4% responded “True” when asked if HPV can cause cervical cancer. Among 
the 40% of women in one study, who had heard of HPV, less than half knew that HPV 
causes cervical cancer (Tiro et al., 2007),   Bair et al. (2008), found 27% (n = 27 of 40) of 
the Latina mothers knew nothing about cervical cancer. Gerend and Magloire (2008) 
noted 92% of the participants knew that HPV is a risk factor for cervical cancer.  
HPV types 16 and 18 are responsible for the majority of HPV-related penile, anal 
and orpharyngeal pre-cancers and cancers in men (Giuliano, 2007). However, only two 
studies in this review addressed the topic of knowing that HPV is a risk factor for anal 
and penile cancer. In one study 15 (14.6%) of the men and 28 (11.6%) of the women 
knew of the HPV-association with penile dysplasia (Baer et.al., 2000). In the study by 
Lambert (2000), prior to an educational intervention, 32% of the students knew the HPV 
association with penile cancer and 88% knew post-intervention.  
African American young adults are at an increased risk of acquiring genital, oral, 
head and neck cancers through the sexual activity of having oral sex with an HPV 
positive partner. Research has indicated that oral transmission is an important health 
concern, particularly because some young adults erroneously view oral sex as a risk-free 
behavior (Remez, 2000). Oral HPV infection is the result of oral sex, in which both men 
and women can be at risk for developing oral cancer related to HPV. A study was 
conducted exploring prevalence rates of oral sex among 13-22 year old sexually-
experienced urban women (Rierden, Forke, Rudy, Hodinka, & Schwarz, 2007). The 
researchers found that 90% of African American women in their sample engaged in oral 
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sex. Young women in the study reported performing oral sex because their partner likes it 
(43%), she likes it (22%), to avoid sexual intercourse (20%), to communicate a greater 
level of intimacy (15%), and to avoid pregnancy (15%). None of the women enacted oral 
sex to prevent sexually transmitted diseases.  
A recent study by the National Cancer Institute (2008) looked at the incidence 
rates for HPV-related oral cancers and found a steady rise in men from years 1973-2004. 
HPV related cancers are becoming about as common as those from tobacco and alcohol. 
Gillison, D’Souza, Westra, Sugar, Xiao, Begum, & Viscidi (2008) suggested men and 
women who had oral sex with five or more partners during their lifetime had a much 
greater chance of having throat cancer. HPV associated oral carcinoma occurs to a higher 
degree in men and does so at a younger age and at a more advanced stage than non HPV 
associated oral cancers. A large study covering 83% of the U.S. population during the 
years 1998–2003, found African American men and women had higher rates of HPV 
associated cancers of the oropharynx and oral cavity. However, the study may have 
under-represented the actual number of cancers diagnosed during this time (Ryerson, 
Peters, Coughlin, Chen, Gilliso, Reichman, & Kawaoka, 2008). The studies in this review 
did not ask questions regarding oral sex as a risk factor for HPV associated cancer. 
HPV Vaccine 
In June 2007, Merck Pharmaceuticals introduced Gardasil® as a cervical cancer 
vaccine for women. As a preventive measure, Gardasil® is the only vaccine that may 
help guard against diseases that are caused by HPV types 6, 11, 16, and 18 (Merck, 
2007). Gardasil® is not a live vaccine, it is a recombinant vaccine. Recombinant vaccines 
are made by genetic engineering, the process and method of manipulating the genetic 
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material of an organism ("Gardasil HPV vaccine," 2007). The federal Advisory 
Committee on Immunization Practices (ACIP) has recommended the vaccine for girls 
and young women 9-26 years of age (CDC, 2006). Gardasil® is given in three injections 
over a six month period (0, 2 months, and 6 months).  
In earlier studies that began in 2005, Merck Research Laboratories began to test 
the efficacy of an HPV vaccine for HPV types 16, 18, 6, and 11 in young men (Geipert, 
2005). Clinical trials evaluated the efficacy, immunogenicity and safety of Gardasil® in 
boys and men 9 to 26 years of age. Vaccine efficacy in men was evaluated in a 
randomized, double-blind, placebo-controlled trial (Merck, 2009). A total of 4,055 men 
were enrolled and received at least one dose of Gardasil® or placebo. Of these 3,457 
were heterosexual men aged 16 to 23 years and 598 were men who have sex with men 
age 16 to 26 years. In the per protocol efficacy analysis, Gardasil® was 90.4 percent 
efficacious against HPV types 6, 11, 16, and 18-external genital lesions ("Gardasil HPV 
vaccine," 2007). In immunogenicity studies, Gardasil® generated robust immune 
responses to HPV types 6, 11, 16 and 18 in boys between 9 to 15 years old and 16 to 26 
year old young men (Coutlee, 2008).  
 In September of 2009 the FDA Advisory Committee recommended approval for 
the use of Gardasil® in boys and young men (Merck, 2009). The Advisory Committee 
agreed that efficacy, immunogenicity and safety data from clinical trials in males 
supported the use of the Gardasil® vaccine in boys and men 9 through 26 years of age for 
the prevention of genital warts caused by HPV types 6 and 11. 
Most of the research to date has focused on vaccine acceptance among adolescent 
females, parents of young women and healthcare providers. Research prior to 2007 
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focused on vaccine acceptance as hypothetical or “when it becomes available.” 
Gardasil® for women was not FDA approved until 2007. Since the approval of 
Gardasil®, several studies have examined factors related to HPV vaccine acceptance 
among young women. Gardasil® for men had been undergoing clinical trials since 2007 
and therefore, a few research studies began to incorporate men in studies involving the 
HPV and the HPV vaccine. Because men play a significant role in the transmission of 
HPV, it is important to include them in HPV research. With the new FDA approved HPV 
vaccine for young men, it is imperative to examine the factors that may influence both 
men and women in HPV vaccine acceptance. The following is a systematic review of the 
empirical literature on young adults HPV vaccine acceptance.  
HPV Vaccine Acceptance  
The following review includes empirical literature regarding HPV vaccine 
acceptance published from January 2007 through 2009. Of the eight studies included in 
the review, all but one of the studies was published after the FDA approval of Gardasil® 
for women. However, none of the articles were published after the October 2009 FDA 
approval of the HPV vaccine for men. 
Two qualitative and six quantitative research studies regarding HPV vaccine 
acceptance are included in this review. One study (Scarinci, Garces-Palacio, Partridge, 
2007) was conducted just prior to Gardasil® approval for women. African American 
(n=27) and Latina immigrants (n=28) were recruited from the community in a city in 
Alabama. Eight focus groups were conducted to explore the acceptability of HPV 
vaccination. When the topic of “likelihood of getting vaccinated” was discussed, African 
American women were more skeptical and had more questions than White women 
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regarding “vaccine effectiveness”, African American women wanted more information, 
however, Latina women felt the vaccine, if FDA approved, would be effective. Barriers 
to receiving the HPV vaccine included vaccine cost and safety. Another barrier 
mentioned by African American women in this study was the Tuskegee research study. 
This fear about misappropriate and dangerous research practice may explain some of the 
hesitation among the African American women in Alabama, to accept the HPV vaccine. 
The quantitative studies in this review utilized a cross sectional survey 
methodology. Three of the studies recruited from college campuses in different parts of 
the United States (Caron et al., 2008; Gerend & Magloire, 2008; Lopez et al., 2008). 
Caron et al. enrolled 293 White (93.5%) women from a University in New Hampshire; 
Gerend and Magloire enrolled 124 men and women (52%; n = 64) from a college in 
Florida. Many of the participants in the study were recruited from a HBCU with 57% 
being African American. Lopez et al. (2008) enrolled 100 men of mixed ethnicities from 
a University in Southern California. One study, Cates et al. (2009) recruited 138 
predominately women (n = 90 Blacks and 48 Whites) from public health clinics across 
rural North Carolina. Although the mean age of the participants was 40, it was inclusive 
of the age criteria of interest in the current research study.  
Lopez et al. (2008) found 36.0% of women knew there was an HPV vaccine for 
women. In a North Carolina study (Cates et al. 2009) that tested about HPV knowledge,  
20% of the women had heard of the vaccine and the responses did not differ by race. 
When African American women in Florida were asked about the vaccine, 65% (n = 39) 
said they were interested in the vaccine. Greater interest was associated with being in a 
committed relationship or dating, being sexually active, having a greater number of 
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sexual partners, and feeling vulnerable to HPV infection (Gerend & Magloire, 2008). 
Interestingly, African American women in rural, NC perceived higher effectiveness of 
the vaccine against cervical cancer than did White women. Furthermore, fewer African 
Americans agreed that vaccines, in general, are beneficial and more agreed that they are 
unnecessary than did White respondents (Cates et al., 2009). In New Hampshire, most of 
the women said they would get the vaccine if it were free (75.3%) and those who would 
not needed more information (63.5%) and 39.4%  were concerned about vaccine safety 
(Caron et al., 2009). Interestingly, this study was the only one to report women who had 
already begun the HPV vaccine series (16.2%). Of the women in this study who had 
previously had sexual intercourse, only 56.5% were concerned about acquiring HPV, 
however, 82.8% agreed that females should be vaccinated. 
Not including studies of parents and physicians, most investigations of HPV 
vaccine acceptability have been conducted with women. Relatively few studies have 
included male participants. As of 2010, there were seven published HPV vaccine related 
research studies that included men interest in their sample (Allen et al., 2009; Ferris, 
Waller, Miller, Patel, Price, Jackson and Wilson, 2009; Gerend & Barley, 2009; Gerend 
& Magloire, 2008; Giuliano et al., 2007; Jones & Cook, 2008; Reiter, Brewer, & Smith, 
2009) 
A study examining HPV vaccine acceptability among young adult men was 
published (Gerend & Barley, 2009). The goals of this study were to: 1) compare two 
different approaches to educating young adult men about HPV vaccination, and 2) to 
identify predictors of HPV vaccine acceptability among young men. The participants 
were college men, Hispanic (n=49, 14%), White (n=298, 84%) and African American 
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(n=4, 16%). Interestingly, at baseline, 39% (n=137) of the men knew that a vaccine to 
prevent HPV infection for men was under development. The study involved students 
reading a 2-page intervention message on HPV infection and the HPV vaccine. Post-test 
results found that the men’s intentions to receive the HPV vaccine were moderately high 
and did not vary by experimental condition (self: m = 3.39; SD = 1.40 vs. self and 
partner: m = 3.78; SD = 1.52). Presenting men with the benefits of the HPV vaccine for 
their female partner(s) did not increase vaccine acceptability over and above presenting 
them with benefits to men alone. Although not statistically significant, sexual activity 
was the only unique behavioral predictor of HPV vaccine acceptance, meaning sexually 
active men reported more interest in the vaccine than non-sexually active men. 
Remaining correlates of HPV vaccine acceptability were generally consistent with those 
identified in previous studies of women.  
 A study examining the variables associated with Human Papillomavirus vaccine 
acceptance by men was conducted by Ferris et al. (2009). Convenience samples of adult 
men from Georgia were recruited from universities as well as various other locations, 
such as, a local military base, family medicine center and elsewhere in the community. A 
total of 571 heterosexual (94.9%) White men (61%) were given a 1-page information 
sheet about HPV and the vaccine. Of the 571 respondents, 33% wanted to be vaccinated 
against HPV, 27% did not and 40% were undecided. Interestingly, more White men were 
undecided about vaccination and a greater percentage of Black men were opposed to 
vaccination. Additionally, educated, younger and not currently sexually active men 
correlated positively with a desire to receive the HPV vaccine. Men who had more than 
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10 sexual partners were interested in the HPV vaccine. Furthermore, knowledge of the 
HPV was also found to correlate positively with HPV vaccine acceptance.  
A qualitative research study exploring college men’s knowledge, attitudes, and 
beliefs about HPV and the HPV vaccine was conducted in 2009 (Allen et al.). Six focus 
groups (n = 45) of predominately White (51%, n= 23 and 24% Black n=11) men from a 
private college in the Northeast participated. Of those who participated, seventy-one 
percent were currently sexually active. One of the focus group topics was “knowledge 
and awareness of the HPV vaccine.”  An example of a sample question: “Have you ever 
heard of a vaccine to prevent HPV?” Many of the participants knew that a vaccine was 
available for women. When asked about receiving the vaccine when it became available 
to men, apprehension regarding costs, accessibility, safety, and side effects was voiced. 
Participants believed that women in general would benefit, “better safe than sorry”.  
Sexual Health Behaviors and HPV 
Although Gardasil® and HPV have been heavily promoted in the media for 
young women; the current message does not address the male factor, especially 
transmission, in relation to this STD. According to the CDC (2008) HPV is passed on 
through genital contact-most often during vaginal and anal sex. HPV is most often 
transmitted through unsafe sexual practices. The sexual behaviors specifically associated 
with greater risk are 1) unprotected sex, 2) intercourse at an early age, 3) multiple male 
sexual partners, and 4) sex with a male partner who has had multiple sexual partners 
(National Cervical Cancer Coalition, 2007).   
Alcohol has often been cited as a contributing factor for abandoning safe sex 
practices, which in turn, leads to possible STDs such as HPV. In the National Institute on 
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Alcohol Abuse and Alcoholism (NIAAA) report, researchers outline the problem of high-
risk drinking on U.S. College and university campuses ("College drinking," n.d.). The 
NIAAA report states that 4,000,000 students between the ages of 18 and 24 had 
unprotected sex and more than 100,000 students between the ages of 18 and 24 report 
having been too intoxicated to know if they consented to having sex (Hingson, Heeren, 
Zakocs, Kopstein, &Wechsler, 2002). 
Aside from complete sexual abstinence, condoms and dental dams are recognized 
as the most effective means of preventing the transmission of STDs. Dental dams are 
square latex pieces worn over the mouth during vaginal or anal oral sex. The continued 
high rate of sexually transmitted diseases suggest that the use of condoms remains below 
what is needed to effectively control the spread of STDs (Bankole, Darroch & Singh, 
1999). A recent study found that condoms can protect against HPV 79% of the time 
(ACS, 2007). In a 28-month study of 123 college women, researchers found that sexually 
active women who used condoms consistently were significantly less likely to contract 
HPV than were women who had not used condoms (Winer, Shu-Kuang, Hughes, Adam, 
Kiviat, & Koutsky, 2005). 
Having multiple sex partners is a high risk health behavior for women. Although 
it has been shown to be a causal factor in the relationship to HPV, having multiple sex 
partners has not been studied extensively in the sexual health literature. Having multiple 
sex partners is often cited as a behavior risk for various negative health outcomes. Moore 
and Davidson state that a high level of participation in premarital sexual intercourse 
among college women is much in evidence, as is the controversy surrounding this trend, 
and the concomitant rise of sexual risk-taking (2006). There are few studies, however, 
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that have focused on the behavior of having multiple sex partners. In 1992, researchers 
from the Alan Guttmacher Institute examined two large national surveys and found a 
substantial percentage of American women have multiple sex partners (Kost & Darroch 
Forrest, 1992). Santelli, Brener, Lowry, Bhatt & Zabin (1998), conducted a survey of 
young adults to assess factors associated with having multiple partners. Of the 63% of 
female respondents who had had sex during the three months of the survey, 15% had had 
two or more partners during that period. In particular, there was evidence that the African 
American young adults in the study exhibited risky behaviors, such as multiple 
partnerships (among men and possibly women), more commonly than was evidenced in 
other racial/ethnic groups (Adimora & Schoenbach, 2002).  
Concern over the HPVs possible impact on sexual behavior has to do with 
“behavioral disinhibition”. Behavioral disinhibition, in this regard, is the perception of 
safety resulting from introduction of the prophylactic HPV vaccine, which may lead to an 
increase in unsafe behaviors and premature sexual activities among adolescents (Saslow, 
Castle, Davey, Einstein, & Ferris, 2007). Failure to adopt less risky practices may be 
related to differences in how adolescents perceive risk that is not immediately and 
personally relevant (Dudley, O’Sullivan, & Moreau, 2002). In a recent study (Caron et 
al., 2008) researchers addressed the controversial idea that vaccination against a sexually 
transmitted infection, specifically HPV, may encourage risky sexual behavior. The 
majority of respondents (65.3%) disagreed with this idea.  
In the current literature review, several studies assessed risky behaviors that might 
put participants “at risk” for an STD, such as HPV. Yacobi et al. (1999) reported that 
95% of the White respondents indicated they took some precaution to prevent STDs. The 
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most common precautions were: remaining in monogamous relationship (71%), using 
condoms (40%) and abstinence (26%). However, of the 40% who use condoms, only 
58% (n=) reported using one the last time they had sexual intercourse.  
In 2005, researchers examined perceived risk of single and married nursing 
students (Denny-Smith et al., 2005). In this sample, married women used condoms less 
than single women, m = 4.88 and 3.10, respectively; high numbers indicate a lack of 
consistent condom use. In the study by Gerend et al (2007), respondents perceived that 
higher risk was associated with being sexually active and having a greater number of 
partners. Both sexual activity and number of partners were unique predictors of perceived 
risk. Furthermore, the mean response for frequency of using protection among the 
sexually active respondents was 4.3 (SD = 1.0), with 58% indicating they “always” used 
protection. In a study whose participants were being treated for cervical dysplasia, 22% 
did not realize that condoms help protect themselves and their partners from the spread of 
HPV (Gerhardt et al., 2000). A focus group study, college men recognized that infection 
was more common among those with multiple sexual partners (“guys who jump around”) 
and those who do not use condoms (“you gotta always wrap it up”) (Allen et al., 2009). 
Use of condoms (85%) and monogamy (79%) were the two most common strategies 
employed by Black college students to prevent STIs. Yet, 23% of students in this study 
did not take any precautions against STIs. Most recently, in a study of vaccine acceptance 
by men (Ferris et al., 2009), 166 of the participants reported having more than 10 female 
sex partners; furthermore, 403 participated in oral sex.  
There were studies in this review that did not assess current sexual behavior, but 
rather, intent to perform “positive” sexual health behaviors. Community study 
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respondents reported that they would use a condom if they or their partner were 
diagnosed with HPV (Holcomb et al., 2004). A study of male perceptions of HPV 
reported that 95.1% of the men indicated that if they were diagnosed with HPV, they 
would use condoms with new sex partners (McPartland et al., 2005). In a 2007 study of 
college women, 41.2% intended to use condoms the next time they have sex and 57% 
intend to reduce their number of sex partners to decrease their probability of contracting 
HPV infection (Lopez & McMahan, 2007). In 2008, condom use among male students 
was explored. Of those who were sexually active, 74.3% were self-efficacious to wear 
condoms during their next sexual encounter and 53.4% intended to reduce their number 
of sexual partners (Lopez et al., 2008) 
Health Belief Model 
 One of the current theoretical frameworks that support the introduction of an HPV 
vaccine is the Health Belief Model (HBM). The HBM was developed in the 1950’s as 
part of an effort by a social psychologist in the United States Public Health Service to 
explain the lack of public participation in health screening and prevention programs. The 
HBM was one of the first models that adapted theory from the behavioral sciences to 
health problems and it remains one of the most widely recognized conceptual frameworks 
of health behavior. Since its inception, the HBM has been adapted to explore a variety of 
long-and short-term health behaviors (Rosenstock, et al., 1994). The HBM is a 
framework for motivating people to take positive health actions and the desire to avoid a 
negative health consequence as the prime motivation. For example, HPV and cervical 
cancer are negative health consequences, and the desire to avoid them can be used to 
motivate African American young adults into receiving the HPV vaccination.  
 40 
 
The Health Belief Model is described in terms of four constructs representing the 
perceived threat and net benefits: 1) Perceived threat consists of both perceived 
susceptibility and perceived severity of a health condition. Susceptibility is one’s 
subjective perception of the risk of contracting a health condition and perceived severity 
is one’s perception of the seriousness of contracting the illness or condition. 2) Perceived 
benefit is the believed effectiveness of strategies designed to reduce the threat of the 
illness or condition. 3) Perceived barriers are the potential negative consequences that 
may result from taking particular health actions, including physical, psychological and 
financial demands. 4) Cues to action include events, either physical or environmental that 
motivates people to take action. A recent addition to the health belief model is the 
concept of self-efficacy, or one’s confidence (Bandura, 1977). This concept was added by 
Rosenstock and others in 1988 to help the HBM better fit the challenges of changing 
habitual unhealthy behaviors, such as being sedentary, smoking, or overeating (Glalnz, 
Lewis, & Rimer, 1997). 
Theories of health behavior can offer a priori predictions about beliefs likely to 
increase the adoption of the HPV vaccine (Brewer & Fazekas, 2007). Most of the studies 
in the current literature review were assessments of HPV knowledge and did not utilize a 
theoretical approach to results interpretation. Nine of the twenty research studies under 
review used constructs of the HBM to assess HPV knowledge and vaccine acceptance. 
When examined, perceived risk of HPV infection was relatively low. In a racially diverse 
sample of college men and women, 56% of the participants disagreed, either strongly or 
moderately, with the statement that they were at risk for HPV infection (Gerend & 
Magloire, 2008). In a study of female nursing students, respondents had low perceived 
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susceptibility and seriousness scores, indicating that they did not believe HPV or cervical 
cancer to be a serious disease threat to them and did not feel susceptible to contracting the 
disease (Denny-Smith et al., 2005).  
Questions regarding perceived susceptibility and perceived severity are often 
phrased as “How likely do you think it is that you will get infected with HPV? What is 
your risk?” and “How severe do you think it would be to have an HPV infection?” 
(Denny-Smith et al., 2005; Lopez & McMahan, 2007; McPartland et al., 2005; Yacobi et 
al., 1999). Only 21% of respondents believed that they were at risk for HPV infection, 
and 56% knew that risk increases with multiple sexual partners. Furthermore, 11 % knew 
risk increased with early sexual activity (Yacobi et al., 2005). On a rating scale ranging 
from 1-5 on men’s perceptions, men did not perceive HPV to be a severe disease for 
themselves, (McPartland et al., 2005). However, most indicated that they perceived HPV 
infection to be more severe for female partners. In 2008 (Lopez et al.), a study of college 
men’s’ perceptions noted 74 % reported high severity and 88.9% susceptibility to HPV 
infection. 
Benefits and barriers to HPV vaccine were assessed in three studies (Caskey et 
al., 2009; Gerend et al., 2007; Reiter et al., 2009). In a recent study of girls and young 
women (Caskey et al., 2009), almost one-third of all respondents stated that “not being 
sexually active” or “concerns about vaccine safety” as the most important reasons for 
foregoing vaccination. Perceived benefits and barriers were assessed as predictors of 
HPV vaccination acceptability among underserved women (Gerend et al., 2007). In this 
study, perceived safety of the HPV vaccine was a significant predictor of vaccine 
acceptability. In a national sample of heterosexual men, moderate levels of perceived 
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barriers (cost and adverse effects) to getting a hypothetical HPV vaccine were reported 
(mean=2.76, SD=0.87) (Reiter et al., 2009). 
Perceived self-efficacy refers to beliefs in ones capabilities to organize and 
execute the courses of action required to produce given levels of attainment (Bandura, 
1997). Furthermore, efficacy is a major basis of action. The construct of self-efficacy was 
measured in two studies. In Lopez and McMahan (2007), the construct of self-efficacy 
was worded “How confident are you in your ability to use a condom the next time you 
have sex to prevent HPV infection?” Participants with greater self-efficacy were more 
likely to request that their partners wear condoms during their next sexual encounter to 
prevent HPV infection. Gerend and Barley (2009) asked the single-item question “I am 
confident in my ability to get the HPV vaccine”. HPV vaccine acceptability was uniquely 
predicted by several health beliefs, including self-efficacy to receive the vaccine.  
The Health Belief Model has been applied to a variety of health issues including 
AIDS, cigarette smoking behavior, and predicting condom use (Rosenstock & Strecher, 
1997). The HBM, as applied to HPV vaccine acceptance, is based on the understanding 
that a person will take a health-related action (HPV vaccination) if that person: 1) feels 
that a negative health condition (HPV and/or HPV related cancer) can be avoided, 2) has 
a positive expectation that by taking a recommended action, she/he will avoid a negative 
health condition (HPV vaccination will avoid negative HPV related outcomes), and 3) 
believes she/he can successfully take a recommended health action (knowledge and risks 
of HPV and negative HPV related outcomes + HPV vaccine = positive health behavior 
decisions made with confidence). The Human Papillomavirus, as well as cancers and 
outcomes related to HPV, are negative health consequences. The knowledge and desire to 
 43 
 
avoid them can be used to motivate African American young adults to practice positive 
sexual health behaviors, to engage in conversations about their sexual health and possibly 
be open to accepting the HPV vaccination.  
The Health Belief Model is a good fit as a theoretical framework for investigating 
HPV vaccine acceptance among African American young adults. The benefits of this 
model are outlined below: 
1) The HBM is a subjective model, so it can be applied to any individual and 
adapted to their own status or position within the health behavior change 
trajectory.  
2) The HBM focuses on one’s beliefs, which makes this model personal and easy 
to tailor to an individual.  
3) The HBM is a good model studying preventive measures, such as obtaining 
the HPV vaccine.  
4) The HBM can also be used to identify particular population characteristics 
and health behaviors, such as those seen within the African American culture.  
5) The concepts of the HBM can be directly applied to specific stages of an 
intervention or program to change one’s health behavior.  
6) The HBM can be easily coupled with another theory or concept, such as 
masculinity ideology, in an effort to “make-up” for certain drawbacks that the 
model alone may hold. 
Although the Health Belief Model is an empirically based theory of understanding 
health related behaviors, some researchers claim the model is limited in addressing such 
psychosocial concerns as attitudes about illness, social support and cultural factors 
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(Damrosch, 1991). Masculinity ideology as a cultural factor will help to further explore 
the contributing factors of HPV vaccine acceptance with African American young adults. 
To date, this model has not been explored in studies on HPV and HPV vaccine 
acceptance. 
Masculinity Ideology 
There is a paucity of research regarding health-related attitudes and behaviors and 
masculinity ideology with African American men and women. Furthermore, the concept 
of masculinity has not been consistently defined, possibly because masculinity exists on a 
continuum comprising power, prestige, and status (Spraggins, 1999). In general, there is 
not one universal set of behaviors that satisfy the requirements of masculinity (Crook, 
Thomas & Cobia, 2009). It has been found that men construct masculinity differently 
depending on their social structural location and the social context (Winterich et al., 
2009). Masculinity has also been viewed from a social constructivist perspective, 
asserting that masculine behaviors and attitudes are learned and produced in social 
institutions and reinforced through human action (Martin & Harris, 2006; Spraggins, 
1999).  
Historically, masculinity theory is positioned in a larger spectrum of sociological 
research that has been undertaken on the subjects of gender and sex (Grodan, 2009). 
Allwood (1998) further asserts that sex role theory and the social construction of gender 
are pivotal points for developing research on masculinity and femininity. However, 
masculinity is more than just a gender role, it refers to a set of culturally created beliefs, 
identities and practices that are constructed through interactions between individuals in 
diverse contexts (Courtenay, McCreary, & Merighi, 2000; Gough, 2006). When 
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definitions of manhood or masculinity include provider and protector, it is important to 
recognize that some men of color face challenges in meeting these roles due to such 
barriers as racism, poverty, lack of education, underemployment, and reduced access to 
service (Thomas, Boss, & Kaggwa, 2004). These constructs most likely result in different 
health beliefs and behaviors.  
Beliefs about masculinity and manhood are deeply rooted in culture and 
supported by social institutions that play a role in shaping the behavioral patterns of men 
in ways that have consequences for health.  Yet, there remains a paucity of research that 
has examined the social concept of masculinity on health practices (Gough, 2006). In the 
healthcare arena, this construct can mean infrequent encounters with the healthcare 
system, delayed attention to symptoms, poor medication compliance and an 
unwillingness to talk openly about health concerns (Williams, 2003). Most recently 
attention has been given to exploring the concept of masculinity within the African 
American community in relation to health behaviors and beliefs. A recent qualitative 
study explored how African American men conceptualize masculinity and how it relates 
to their health behaviors (Duck, 2009). The study found that being sexually active is an 
important component of African American men’s notion of masculinity.  
African American men who have sex with women are almost nonexistent in the 
social science literature (Bowleg, 2004). In her study regarding HIV concerns, Bowleg 
found this puzzling because many African American men’s HIV risk behaviors 
(particularly injection drug use) form the leading exposure categories of Black women’s 
HIV risk. This philosophy can be further applied to African American men’s HPV risk 
behaviors (particularly unprotected sex) and the leading exposure categories of African 
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American young women’s HPV risk. With regard to HPV exposure, the concept of 
masculinity from both the male and female perspective may play a role in sexual health 
behaviors of African American young adults. In a recent discourse regarding the 
performance of masculinity in love relationships, Wallace (2007) states that “since Black 
girls are taught the same lessons about manhood, as women, their own ideas of what it 
means to be a Black man are also skewed.”   
There is a constellation of standards and expectations associated with the 
traditional male role in the Western world (Levant & Richmond, 2007). This type of 
masculinity ideology is referred to as “hegemonic masculinity” to underscore its role in 
the dominance of White heterosexual men over women and racial, ethnic, and sexual 
minorities. David and Brannon (1976) identified four norms of traditional masculinity: 1) 
“no sissy stuff” (that men should avoid feminine things), 2) “the big wheel” (that men 
should strive for success and achievement), 3) “the sturdy oak” (that men should not 
show weakness), and 4) “give ‘em hell” (that men should seek adventure, even if 
violence is necessary).  
For men of color, who are marginalized and not allowed these mainstream ways 
to enact male gender roles, risk-taking behavior provides a way in which they can attempt 
to establish themselves as men. Traditional masculinity ideology supports those health-
related attitudes and behaviors that put men at risk for poor health, however, it is not clear 
what particular aspects of traditional masculinity may contribute to poor health outcomes 
in African American men and women (Wade, 2009). A recent study by Wade (2008) 
found that nontraditional masculinity was a predictor of health behaviors conducive to 
African American men’s behavior. Thus far the concept of African American traditional 
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masculinity ideology among both male and female young adults in regard to HPV and 
HPV vaccine acceptance has not been explored in the literature.    
Summary 
This chapter provided an extensive review of the empirical literature related to 
HPV, HPV-related cancer, HPV vaccine acceptance, the Health Belief Model, and 
Masculinity Ideology. A review of the literature revealed young adults in the United 
States generally lack the awareness or knowledge and are misinformed when it comes to 
HPV, putting them a higher risk of being infected with HPV. The literature review 
revealed a  number of gaps in the literature. First, HPV research has not been conducted 
in the State of Missouri, a state with one of the highest STD rates in the country. Second, 
very few studies included African American young adults in their sample population, 
who are disproportionately affected by STDs. Third, few studies utilized a theoretical 
framework, however, the HBM was used most commonly but only a few of the 
constructs were measured in each study. A more comprehensive use of the HBM is 
needed. Fourth, the concept of masculinity ideology has not been explored in relation to 
HPV and HPV vaccine acceptance. This concept may provide additional information 
along with the to the HBM when applied to research with African American young 
adults.  
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CHAPTER THREE: METHODOLOGY 
 The focus of this study was to examine factors that may contribute to HPV 
vaccine acceptance in African American young adults. This chapter provides an overview 
of the methods used to guide the study; study design, data collection, and sample 
characteristics. The psychometric properties of each instrument are described in detail 
and include the Knowledge and Attitudes towards Human Papillomavirus (HPV) and 
HPV Vaccination Survey, demographic information and the Male Role Norms Inventory-
Revised. Data analysis and screening procedures are described fully. 
Study Design 
 This study utilized a cross-sectional survey design to elicit information from 
African-American young adults regarding their knowledge and beliefs about HPV. The 
HBM served as the theoretical framework for this study, with the additional concept of 
masculinity ideology. The HBM was used to examine African American young adults’ 
perceived susceptibility and perceived seriousness of HPV. The perceived barriers and 
perceived benefits to an HPV vaccine were also examined. Self-efficacy was looked at in 
relation to one’s intention to receive the HPV vaccine. In addition to the concepts 
described, the HBM suggest that behavior is also influenced by cues to action such as 
events, people or things that influence people to change behavior (Hayden, 2009). 
However, “cues to action” were excluded from this study, since the researcher was not 
interested in determining what cues African American young adults take, but rather in 
determining their knowledge and contributing factors of HPV vaccine acceptance. The 
concept of masculinity ideology was also explored. The survey included demographic 
information as well as questionnaire response.  
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 The dependent variable of interest was identified as HPV vaccine acceptance 
operationalized as intention to receive the HPV vaccine. The independent variables of 
interest included: 1) HPV knowledge, 2) perceived susceptibility to HPV, 3) perceived 
seriousness of HPV, 4) perceived benefits of vaccination, 5) perceived barriers to 
vaccination, 6) self-efficacy, and 7) masculinity ideology. 
Data Collection 
Approval for this study was obtained on June 22nd, 2010 from the University of 
Missouri-Columbia Health Sciences Institutional Review Board. Additionally, IRB 
approvals were obtained from each of the ten study sites, including: Harris Stowe State 
University in St. Louis, Lincoln University in Jefferson City, Saint Louis Community 
College campuses (Florissant Valley, Forest Park, Meramec, and Wildwood) Truman 
State University in Kirksville, the University of Missouri at Columbia, the University of 
Missouri at Rolla, and the University of Missouri at Saint Louis. The research study 
employed an e-mailed link recruitment strategy (Appendix A). An e-mail invitation to 
participate in the study was sent to potential participants via their college or university e-
mail address. If a student was interested in participating, they were instructed to click on 
the embedded secure SurveyMonkey link. SurveyMonkey is an on-line survey 
development software program. This software program allows researchers to develop 
surveys as well as create a link to the survey, which may be placed in any format such as 
an e-mail. Once on the SurveyMonkey site, the participant was presented with the 
informed consent document (Appendix B). The consent document provided information 
about the purpose and process of the study, university and research contact information, 
and potential benefits and risks. Informed consent acknowledgement was obtained 
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through participants clicking on an agreement button which stated they have read the 
informed consent and would like to participate in the study. The total time for study 
participation, including demographic and survey response completion, was approximately 
20 minutes.  
Participants 
A non-probability convenience sample was utilized in this research study. A 
representative at each college or university site was identified and agreed to be the 
school’s contact person for the accessed student population. This contact person sent an 
e-mail invitation to the students on behalf of the researcher. The link to the survey on 
SurveyMonkey was embedded in the e-mail letter of invitation to participate in the study. 
The target population for the study was African-American young adult men and women, 
between the ages of 18 and 26, because 26 is the age limit recommended for the vaccine. 
Students enrolled at one of the public university or college study sites between September 
2010 and March 2012 were invited to participate in the study. Missouri is a large 
Midwestern state; therefore, participants were recruited from multiple sites in an attempt 
to obtain geographical diversity. The participant’s e-mail address was not connected to 
the survey response in any way. The surveys were anonymous and confidentiality was 
assured throughout the survey. Incentive for participation was the possibility of winning 
one of several (two per study site) $25 gift cards in return for participation. At the end of 
the survey, participants were asked to leave any form of contact information, such as an 
e-mail address or phone number, if they would like to be entered into the drawing for a 
gift card. 
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Instrumentation 
Demographic Questionnaire. The demographic questionnaire was used to 
collect information about study participants. The questionnaire included items on 
participants’ zip codes, gender, age, self-identified race/ethnicity, and current year in 
college. Participants were asked questions regarding their relationship status, sexual 
orientation and age at first intercourse. Questions based on Gerend and Barleys’ (2009) 
study assessed awareness of HPV, if participants had heard of HPV, where they obtained 
information on HPV, Pap test knowledge and history, and condom use. In addition, 
questions were asked regarding sexual risk factors, based on Gerend and Barley’s (2009) 
model.  
Knowledge and Attitudes towards Human Papillomavirus (HPV) and HPV  
 
Vaccination Survey. A literature search of published surveys on HPV and the HPV 
vaccine acceptance was conducted. At the time, there were not many existing measures 
for HPV and HPV vaccine acceptance (Denny-Smith, 2006; Ingledue, Cottrell, & 
Bernand, 2004; Tiro et al., 2007). In most cases, researchers developed questionnaire 
items or adapted them from published research (Allen et al., 2010). For the current study, 
the Men’s Health Attitudes Study: Pre-survey (MHAS) developed by Gerend (2009) was 
selected. Permission to use the survey with modifications was requested and granted by 
the author. Studies that have used the MHAS include research on HPV awareness, and 
knowledge, beliefs and attitudes toward HPV. In addition, the question items in this 
instrument have been validated in prior studies with racially diverse samples of young 
adults (Gerend, Lee, & Shepherd, 2007; Gerend & Magloire, 2008; Gerend & Barley, 
2009).  
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The MHAS survey was originally developed for a study to identify predictors of 
HPV vaccine acceptability among young adult men (Gerend & Barley, 2009). In the 
study, it was hypothesized that men, particularly those men who were in a committed 
romantic relationship with a woman, would display greater vaccine acceptability when 
exposed to the partner protection benefits of the HPV vaccination. The study included a 
2-page intervention message on HPV infection and the HPV vaccine. Although the 
psychometric properties of the survey were not published, the author, Dr. Gerend, drew 
items from prior research in this area (Gerend et al., 2007; Gerend & Magloire, 2008; 
Gerend & Shepherd, 2008; Gerend & Shepherd, 2007; (Gerend, Shepherd, & Monday, 
2008); McPartland et al., 2005). For the purpose of this research study, only questions 
that related to the constructs of interest were included in the modified version. The 
current study does not include the intervention, the questions related to the intervention, 
or those related to being in a real or fictitious romantic relationship. 
The 73-item MHAS survey includes questions about HPV and HPV vaccine 
acceptance (Gerend & Barley, 2009). The MHAS survey items are congruent with the 
definitions of the concepts of knowledge, intention to vaccinate, and the constructs of the 
Health Belief Model: perceived threat (susceptibility and severity), perceived benefits, 
and perceived barriers, and self-efficacy. For the purposes of this study, the Knowledge 
and Attitudes towards Human Papillomavirus (HPV) and HPV Vaccination Survey (a 
modified version of the MHAS) was developed with 121 items included in the survey 
(Appendix C). The modification of the survey included deletion of certain items, 
additional questions added as well as response alternatives inserted on the Likert scales. 
When asked about the modifications, particularly response alternatives, the original 
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author stated that she thought it was a good idea to add in the descriptors, especially since 
participants were completing the survey online. Dr. Gerend further stated that “anything 
we can do to make the survey easier for participants to understand is usually a good thing 
to do” (M. Gerend, personal communication, January, 2009). 
Knowledge. Questions in this section are scored as “true”, “false”, or “don’t 
know”. For example: 1) Genital warts are caused by HPV, 2) Most people with genital 
HPV have no visible signs or symptoms, and 3) HPV can cause cancer of the penis or 
anus in men. The MHAS included 14 knowledge questions. For this study, one question 
was changed from “Vaccines to prevent HPV infection for men are under development” 
to “There is a vaccine to prevent HPV infection that is available for men”. This change 
reflects the FDA approval of the HPV vaccine for men, which was not available at the 
time the MHAS was developed. Three additional questions addressing HPV-related 
cancer were included in the survey: “HPV can cause oral cancer in men”, “HPV can 
cause anal cancer in women”, and “HPV can cause oral cancer in women”. A total of 17 
knowledge questions comprised the knowledge scale with 1 point given for each correct 
answer (0-17).  Zero points were given for incorrect and “don’t know” responses. A 
higher total score is reflective of greater HPV knowledge. The knowledge scale has good 
internal consistency, with a Cronbach alpha coefficient of .77. Values above .7 are 
considered acceptable (DeVellis, 1991, p.85). 
Intention to vaccinate. Intention to vaccinate against HPV was assessed using 
five items based on prior research (Gerend & Barley, 2009; Gerend & Shepherd, 2007; 
Gerend et al., 2008). Five questions were included in this section and scored on a 6-point 
Likert scale from 1 = “Very Unlikely” to 6 = “Very Likely”. For example, 1) How likely 
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is it that you’ll try to get more information about the HPV vaccine? 2) How likely is it 
that you’ll make it a priority to get the HPV vaccine? And 3) How likely is it that you’ll 
actually get the HPV vaccine? Scores were summed to create a total intention score, 
where a lower score indicates less intention and a higher score indicates greater intention. 
The intention to vaccinate scale showed a Cronbach alpha coefficient of .93 which is 
considered to be excellent (George & Mallery, 2003). 
Perceived Susceptibility. Items in this scale were used to assess perceived 
susceptibility. Four questions were included in this section and scored on a 6-point Likert 
scale from 1 = “Very Unlikely” to 7 = “Very Likely”. For example, 1) How likely is it 
that you’ll get genital HPV in the next 10 years? And 2) How likely do you think it is that 
a current or recent partner(s) of yours is infected with HPV? Scores were summed to 
create a total perceived susceptibility score, where low scores indicate low perceived 
susceptibility and high scores indicate high perceived susceptibility. The perceived 
susceptibility scale showed a Cronbach alpha coefficient of .84 which is considered to be 
good (George & Mallery, 2003). 
Perceived Severity. Two questions on perceived severity were included in this 
section and scored on a 5-point Likert scale from 1 = “Not At All” to 5 = “Very Severe”. 
For example, 1) How severe do you think genital HPV infection would be for yourself? 
and 2) How severe do you think genital HPV infection would be for your partner? Scores 
were summed to create a total perceived severity score, where low scores indicate low 
perceived severity and high scores indicate high severity. The perceived severity scale 
showed a Cronbach alpha coefficient of .94 which is considered to be excellent (George 
& Mallery, 2003). 
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Perceived Benefits. Four questions on perceived benefits were included in this 
section and scored on a 6-point Likert scale from 1 = “Disagree Strongly” to 2 =“Agree 
Strongly”.  For example, 1) The HPV vaccine reduces a man’s chances of developing 
HPV related cancers, and 2) Getting the HPV vaccine may be a good thing to do for my 
health. Scores were summed to create a total perceived benefits score, where low scores 
indicate low perceived benefits and high scores indicate high perceived benefits. The 
perceived benefits scale showed a Cronbach alpha coefficient of .81 which is considered 
good (George & Mallery, 2003). 
Perceived Barriers. Nine questions on perceived barriers were included in this 
section and were prefaced with the following “Would the following factors prevent or 
keep you from getting vaccinated against genital HPV in the future?” For example, 1) 
Having to pay a lot for the vaccine, 2) Fear that you could get HPV from getting the 
vaccine, and 3) Having to get shots. Items are scored as either “yes” or “no” with each 
“yes” response receiving a score of 1. A total score is obtained (range of 0-9) with a 
higher score indicating more perceived barriers.  The perceived barriers scale showed a 
Cronbach alpha coefficient of .70 which is considered acceptable (George & Mallery, 
2003). 
Self-efficacy. Two questions on self-efficacy were included in this section. They 
are scored on a 6-point Likert scale from 1 = “Disagree Strongly” to 6 = “Agree 
Strongly”. For example, 1) I am confident in my ability to get the HPV vaccine and 2) 
Whether I get vaccinated against HPV is under my personal control. Scores were 
summed to create a total self-efficacy score, where lower scores indicate lower self-
efficacy and high scores indicate higher self-efficacy. The self-efficacy scale showed a 
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Cronbach alpha coefficient of .65 which is considered minimally acceptable (DeVellis, 
1991, p. 85). 
Male Role Norms Inventory-Revised. The Male Role Norms Inventory-Revised 
(MRNI-R) (Levant et al., 2007; Levant et al., 2010) was used to assess traditional 
masculinity ideology among African American young adults. For African American 
males who are marginalized and are not allowed mainstream ways to enact male gender 
roles, risk-taking behavior provides a way in which they can attempt to establish 
themselves as men (Courtenay, 2000b). Traditional masculinity ideology supports those 
health-related attitudes and behaviors that put men (and possibly women) at risk for poor 
health (Wade, 2009). This study examined the relationship between traditional 
masculinity ideology and African American young adult’s intention to receive the HPV 
vaccine. 
The MRNI-R is a 53-item measure with items rated on a 7-point Likert scale (1 = 
strongly disagree to 7= strongly agree). The items used in the MRNI-R are framed to 
make comparisons between men and women as opposed to many extant scales which 
make statements about men in relation to male role norms (Levant & Richmond, 2007). 
The instrument includes seven theoretically-derived norms of traditional masculinity 
ideology including: 1) Avoidance of Femininity (eight items, e.g., “Men should not wear 
make-up” and “Men should watch football instead of soap operas”); 2) Fear and Hatred 
of Homosexuals (ten items, e.g., “Homosexuals should never marry” and “All 
homosexual bars should be closed down”); 3) Extreme Self Reliance (seven items, e.g., 
“A man must be able to make his own way in the world” and “ A man should never count 
on someone else to get the job done”); 4) Aggression (seven items, e.g., “Boys should be 
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encouraged to find a means of demonstrating physical prowess” and “ Men should get up 
to investigate if there is a strange noise in the house at night”); 5) Dominance (seven 
items, e.g., “A man should always be the major provider in his family” and “In a group, it 
is up to the men to get things organized and moving ahead”); 6) Non-relational Attitudes 
toward Sexuality (six items, e.g., “Men should always take the initiative when it comes to 
sex” and “A man should get up to investigate if there is a strange noise in the house at 
night”); and 7) Restrictive Emotionality (eight items, e.g., “One should not be able to tell 
how a man is feeling by looking at his face” and “Men should not be too quick to tell 
others that they care about them”). A traditional masculinity total scale score is obtained 
by averaging the scores on all 53 items (Levant, Hassan, & Smalley, 2010). 
Data Analysis and Screening 
 Data from each 121-item questionnaire were exported from SurveyMonkey to an 
Excel spreadsheet. The researcher examined the data to ensure all data points were 
transferred successfully. Questionnaires were completed over a continuum which allowed 
the researcher to clean the data and make appropriate decisions as data collection 
progressed over time. There were 558 questionnaires received, however, 207 were 
excluded for several reasons: Initially, demographic question items were placed at the 
end of the survey. The researcher believed, as did Dillman (1978), that recipients who 
had already invested the time to answer the more “appealing” survey items first, would 
be more likely to complete the “ordinary” demographic questions at the end of the 
survey. This technique was recommended in seven of nine social work research 
textbooks (Green, Murphy, & Snyder, 2000). However, as the data cleaning process 
began, it was realized that recipients were not completing the demographic questions. 
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This was a huge concern considering the fact that inclusion criteria required a) the 
participant be between the ages of 18-26 and b) that they be of African-American 
descent. In order to test gender differences as stated in hypotheses 2, the researcher would 
need to distinguish between male and female participants. The gender question item was 
also at the end of the survey (n=60). Therefore, the researcher re-formatted the on-line 
survey and placed the demographic question items at the beginning of the survey.  
A second exclusion of surveys occurred after the demographic section was re-
formatted. When the data were screened again, survey respondents who were found to be 
outside of the 18-26 year age range and not of African American descent were removed 
from the data set (n=147).  
Data from each survey were then entered into a database file and analysis was 
completed using the statistical package software IBM SPSS Statistics Version 19 ("SPSS 
Version 19," 2012). Upon completion, data were cleaned utilizing a visual inspection of 
the 351 cases. The researcher employed a random data check as a step in data entry 
accuracy. Frequencies were then run on all of the variables to check for coding accuracy, 
outliers and missing data. As stated in Heppner & Heppner (2004) missing data can 
reduce the credibility of the data set and may also raise questions about why certain items 
were not answered. There was not an observed pattern of missing data that would suggest 
a certain item caused the participant to exit the survey. There were relatively few cases 
which had larger amounts of missing data. The researcher decided to leave the data as is, 
with the missing values in place. Therefore, all 351 cases were included in the final data 
analysis with missing data coded as such.  
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Prior to data analysis, assumption of normality for each variable was checked and 
the scales were assessed for internal consistency. Perceived benefits, perceived severity, 
perceived susceptibility, self-efficacy, and traditional masculinity ideology displayed 
some skewness and/or kurtosis as indicated by values greater than 1. The variables of 
intention to vaccinate and perceived barriers were close to normal distribution with 
skewness and/or kurtosis values between −1 and+1.  Inspection of the normal probability 
plots on all variables was observed. Each variable displayed a relatively straight line 
which suggests normal distributions. In research, particularly the social sciences, scores 
on the dependent variable are not always normally distributed (Pallant, 2010). Pallant 
states that with a large sample size (e.g. 30+); the violation of normality should not cause 
any major problem.  
Summary 
 This chapter explained the study methodology, including study design, data 
collection, participants, instrumentation, data analysis and screening procedures. Chapters 
four and five will present study results and discussion, respectively. There is a gap in the 
literature about African American young adults (ages 18-26), regarding their knowledge 
of HPV and the HPV vaccine. This research study is intended to contribute to the 
growing body of work that provides an empirical basis of support for appropriate clinical 
and educational interventions regarding HPV and HPV vaccine acceptance with African 
American young adults. 
 
 
 
 60 
 
CHAPTER FOUR: RESULTS 
The purpose of this study was to examine the contributing factors of HPV vaccine 
acceptance among African American young adults. The statement of the problem was 
discussed in Chapter one. An extensive review of the literature pertaining to knowledge 
of the Human Papillomavirus, HPV vaccine, health behaviors, the Health Belief Model, 
as well as, masculinity ideology was provided in Chapter two. The methods and 
procedures used to conduct the study were outlined in Chapter three. The following 
chapter will summarize the results of the participant demographics and sexual risk 
factors, as well as explain the statistical analyses performed for each of the four 
hypotheses.    
Participant Description of Demographics and Sexual Risk Factors                      
 Descriptive data about the demographic and sexual risk factors of participants are 
presented in Table 1, 2 and 3 respectively. Table 1 describes the overall 
sociodemographic information from the entire sample of men and women. The sample 
population consisted of 351 students attending one of ten public colleges and universities 
in Missouri. The majority of the respondents were female 80.6% (n=283), with men 
representing 19.4 % (n=68) of the sample. The mean age was 20.78 (SD=2.10) and all 
participants were between 18 and 26 years old, the maximum age at which young men 
and women can receive the HPV vaccine. The year in college was equally represented 
from freshman (20.6%, N=14 men and 20.5%, n=58 women) through senior year (26.5%, 
n=18 men and 23.0%, n=85 women). However, graduate students were least represented 
in the sample (8.8%, n=6 men and 6.4%, n=18 women). The large number of participants 
reported being in a committed relationship (37.9%, n=133), with 77(21.9%) reported as 
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currently single and dating, 13 (3.7%) being married. Overall, a large percentage of 
students had heard of HPV prior to the survey (85%, n=58 men and 96.1%, n=272 
women). There are several avenues for individuals to receive information regarding HPV. 
Interestingly, men and women in this study receive information from the same top three 
sources. The men receive information regarding HPV from their healthcare provider 
(44.1%), the television or radio (42.6%) or from a class (42.6%). Similar to men, women 
hear about HPV from their healthcare provider (76.3%), television or radio (51.9%) or 
from a class (44.8%).  
Table 2 describes the sociodemographic characteristics and sexual risk factors of 
the freshman/sophomore and junior/senior educational level students. In regards to 
relationship status, the data was very similar across the two divisions. Many of the 
participants were single and actively dating (21% freshman/sophomore and 21% 
junior/senior) or single and in a committed relationship (38% freshman/sophomore and 
40% junior/senior). Several students reported that they are not currently dating (39% 
freshman/sophomore and 35% junior/senior). The difference between upper and lower 
division students having heard of HPV prior to the survey was insignificant (95% 
freshman/sophomore and 92% junior/senior). When looking at sources from which  the 
students get information regarding HPV, the top three sources were very similar to male 
and female distribution; healthcare provider (76% freshman/sophomore and 67% 
junior/senior), class (54% freshman/sophomore and 38% junior/senior) and television or 
radio (44% freshman/sophomore and 53% junior/senior). 
Table 3 details the overall sexual risk factors of both the men and women in the 
study. Forty-five percent (n=45) young men and 64% (n= 182) of the young adults in this 
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study report having had sexual intercourse on or before the age of 18. One hundred and 
fifty six (44.4%) reported that they had no current sexual partner and 22.5 % (n=79) 
stated that they have never had sexual intercourse. Of those who were in a relationship at 
the time of the survey, 12.3 % (n = 43) reported that they do not use condoms to prevent 
sexually transmitted diseases. Participants who were sexually active were asked the 
question, “Did you use a condom the last time you had sex?” Of the 247 participants, 46 
% (n=124) said they did not use condoms during their last sexual encounter. When asked 
“Which of the following puts you at risk for HPV?” the participants believed that having 
many sex partners (83%) and having frequent sex (45%) were the most risky behaviors 
for contracting HPV.  
Table 1. 
Sociodemographic Characteristics of African American Men and Women (N=351) 
 
                                Men            Women 
 
Characteristics    Mean SD N %    Mean SD N %    
 
Age (years)   20.71 1.72 68 19.4 20.80 2.18 283 80.6 
Class rank   
1st year     14 20.6   58 20.5 
2nd year       9 13.2   70 24.7 
3rd year     21 30.9   72 25.4 
4th year     18 26.5   65 22.9 
>5th year       6   8.8   18   6.4 
Relationship Status 
Single and dating    18 26.5   59 20.8 
Single, but in a committed relationship 21 30.9            112  39.6 
Not currently dating    28 41.2            100 35.3 
Married       1   1.5   12   4.2 
Sexual orientation 
Sex with women    57 83.8   10   3.5 
Sex with men       5   7.4            260 91.9 
Sex with men and women     6   8.8   13   4.6 
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Heard of HPV     
Yes      58 85.0            272 96.0 
No      10 15.0   11   4.0 
Where heard of HPV 
Healthcare provider    30 44.1            216 76.3  
Friend      18 26.4   83 29.3 
Partner        4   5.8   13   4.5 
Class      29 42.6            127 44.8 
Television or radio    29 42.6            147 51.9 
Family      11 16.1   72 25.4 
Internet     22 32.3   89 31.4 
Magazine     10 14.7   73 25.7 
 
 
 
Table 2. 
Sociodemographic Characteristics and Sexual Risk Factors  of Freshman/Sophomore 
and Junior/Senior African American College Students (N=327) 
 
                                Freshman/Sophomore  Junior/Senior 
 
Characteristics      N %      N %    
 
Freshman/Sophomore    151 46.2    
Junior/Senior         176 53.8 
Relationship Status 
Single and dating    32 21.2   37 21.0  
Single, but in a committed relationship 58 38.4   70 39.8 
Not currently dating    59 39.1   61 34.7 
Married       2   1.3     8   4.5    
Heard of HPV     
Yes               144 95.4                       162 92.0 
No        7   4.6   14   8.0 
Where heard of HPV 
Healthcare provider    114 75.5   119 67.6 
Friend        41 27.2     51 29.0 
Partner          6   4.0     10   5.7 
Class        82 54.3     67 38.1 
Television or radio      67 44.4     93 52.8 
Family        44 29.1     35 19.9 
Internet       48 31.8     56 31.8 
Magazine       41 27.2     35 19.9 
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Sexually Active 
Yes      112 74.0    138  78.0 
No        39 26.0     38  22.0 
Current Partner Use of 
Condom to Prevent STDs 
Always      40 26.0     43 24.0  
Not always      54 36.0     59 34.0 
No current partner                57 38.0     74 42.0 
Know What a Pap Test Is 
Yes  
Correct response     108 71.5   134 76.1 
Yes, 
 Incorrect response       43 28.5     42 23.9 
You or any sexual partner 
Ever had abnormal Pap test 
Yes      24 15.9   37 60.7 
No      61 40.4   67 38.1 
Don’t know     34 22.5   43 24.4 
Specific risk factor for HPV 
Having sex at an early age*   59 39.3   64 36.4  
Having frequent sex    72 48.0   73 41.5  
Having many sex partners*            130 86.7            141 80.1  
Using birth control pills     6   4.0     9   5.1  
Alcohol use     18 12.0   17   9.7 
Being under the age of 25*   35 23.3   50 28.4  
Drug use     26 17.3   21 11.9    
Note. Graduate students are not included in the totals represented in the table (n=24). 
*Generally accepted as risk factors for HPV. 
 
 
Table 3. 
Sexual Risk Factors of African American Men and Women (N=351) 
 
                               Men (n=68)           Women (n=283) 
 
Risk Factor    N %    N % 
Sexually Active 
Yes     56 82.4    216 76.3 
No     12 17.6      67 23.7 
Age at First Intercourse 
12       3   5.3       5   2.3  
13       3   5.3     10   4.6 
14       5   3.5     19   8.8 
15       5   8.9     29 13.4 
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16                10 17.8     38 17.6 
17                10 17.8     36 16.7 
18      9 16.1     45 20.8 
19      6 10.7     21   9.7 
20      2   3.5      7   3.2 
21      3   5.3      3   1.4 
22      0   0.0      2   0.9 
23      0   0.0      1   0.5 
Never had sex    12 21.4     67 31.0 
Current Partner Use of 
Condom to Prevent STDs 
Always    16 39.0     69       41.0      
Not always    25 61.0              100 59.0 
No current partner              27 40.0                114 40.0 
Know What a Pap Test Is 
Yes,  
Correct response    31 45.6    230 81.3 
Yes, 
 Incorrect response    37 54.4      53 18.7 
You or any sexual partner 
Ever had abnormal Pap test 
Yes       5   7.4      65 23.0 
No     19 27.9    119 42.0 
Don’t know    44 64.7      99 35.0 
Specific risk factor for HPV 
Having sex at an early age*  19 27.9    117 41.3 
Having frequent sex   30 44.1    127 44.9 
Having many sex partners*  54 79.4    236 83.4 
Using birth control pills    1   1.5      18   6.4 
Alcohol use    10 14.7      30 10.6 
Being under the age of 25*  12 17.6      83 29.3 
Drug use    14 20.6      37 13.1 
Note. N=represents those who responded ‘yes’ to these are risk factors. 
*Generally accepted as risk factors for HPV. 
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Research Questions and Hypothesis 
Research Question 1 
Is there a relationship between knowledge, contributing factors of the Health 
Belief Model (perceived susceptibility, perceived seriousness, perceived benefits, 
perceived barriers, and self-efficacy) and one’s acceptance of the HPV vaccine among 
African American young adults?  
Hypothesis 1 
Greater knowledge about HPV, higher perceived susceptibility to HPV, higher 
perceived seriousness of HPV, greater perceived benefits of the HPV vaccine, and 
greater self-efficacy will increase the likelihood of being willing to get the HPV vaccine, 
while greater perceived barriers will reduce HPV vaccine acceptance among African 
American young adults.  
A standard multiple regression analysis was used to assess HPV knowledge and 
the constructs of the Health Belief Model(perceived susceptibility, perceived seriousness, 
perceived benefits, perceived barriers, and self-efficacy)  to predict one’s intention to 
accept the HPV vaccination. Regression results indicated that the overall model 
significantly predicts African American young adults intention to receive the HPV 
vaccine, R2=.404, F6,316=35.7, p<.05. Meaning, there is only a 5 in a 100 (or less) chance 
that there is not a relationship between the variables included in the model. The R2 value 
of 40% indicates that just under half of the variability in African American young adult’s 
intention to receive the HPV vaccine is predicted by variables included in the model. Of 
the six variables included in the model, three (perceived susceptibility, perceived benefits 
and perceived barriers) make statistically significant unique contributions to the equation. 
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A summary of the regression coefficients is presented in Table 4. It was found that 
perceived susceptibility (B =.16, p<.05), perceived benefits (B =.73, p<.05) and perceived 
barriers (B =-.09, p<.05) significantly contributed to one’s intention to accept the HPV 
vaccination. In other words, for each additional point of perceived susceptibility and 
perceived benefits, intention to accept the vaccine was increased by 0.16 and 0.73 points, 
respectively. For each additional point of perceived barriers, the intention to accept the 
vaccine was decreased by 0.09. 
Table 4. 
 
Regression Analysis Summary for Perceived Susceptibility, Perceived Severity, Perceived 
Benefits, Perceived Barriers, Self-efficacy, and Knowledge Variables Predicting HPV 
Vaccine Intentions  
 Variable      B  SE B    β    t     p  
 
Perceived susceptibility   .160  .058  .122  2.75  .006*  
 
Perceived severity     .046  .047  -.259  -1.89  .066  
 
Perceived benefits   .726 .066 .541 11.006  .000* 
 
Perceived barriers         -.089 .029 -.142 -3.088  .002* 
 
Self-efficacy    -.007 .076 -.005 -.095  .924 
 
Knowledge    .032 .020 .074 1.602  .110 
Note. R2=.40(*p<.05). Perceived severity, self-efficacy and knowledge were not 
significant predictors. 
 
 
Research Question 2 
Is there  a gender difference related to knowledge, contributing factors within the 
Health Belief Model (perceived susceptibility, perceived seriousness, perceived benefits, 
perceived barriers, and self-efficacy) and one’s acceptance of the HPV vaccine among 
African American young adults?  
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Hypothesis 2 
 African American young women will have more knowledge about HPV, perceive 
their susceptibility to HPV as higher, perceive the seriousness of HPV to be higher, 
perceive greater benefits of the HPV vaccine, have greater self-efficacy, perceive fewer 
barriers to vaccination, and be more likely to accept HPV vaccination, compared to 
African American young men. 
An independent samples t-test was conducted to see if women expressed greater 
knowledge regarding HPV when compared to men. There was a statistically significant 
difference in scores for males (M = 10.13, SD = 3.87) and females (M = 11.81, SD = 
3.08), t(341) = 3.83, p = .001, one-tailed). This indicates that females have slightly more 
knowledge regarding HPV than their male counterparts. See Table 5 for HPV knowledge 
items and percent responding correctly by gender. 
Due to the unequal group sample sizes, a Mann-Whitney U Test was also 
conducted. The Mann-Whitney U Test revealed a significant difference in knowledge 
regarding HPV. The results of the Mann-Whitney test showed a significant difference in 
intention to accept the HPV vaccination among males (Md = 11.00, n = 68) and females 
(Md = 12.00, n = 275), U = 6517.50, z = -3.894, p =. 00. 
Table 5. 
HPV Knowledge Responses of African American Men and Women 
         Men  Women 
        (n=68)  (n=275) 
      Correct 
Items      Answer n % n %  
 
 
Most people with genital HPV have 
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 no visible signs or symptoms.  True  57 83.8 249 90.5 
 
HPV can cause herpes.   False  36 52.9 152 55.2 
 
Genital warts are caused by HPV.  True  46 67.6 175 63.6 
 
HPV can cause cervical cancer in women. True  59 86.7 263 95.6 
 
HPV can cause oral cancer in men.   True  41 60.2 192 69.8 
 
HPV can cause anal (rear end) cancer 
 in women.      True  50 73.5 20.0 72.7 
 
If a woman’s Pap smear is normal,  
she does not have HPV.   False  20 29.4 123 44.7 
 
An abnormal Pap smear may indicate  
that a woman has HPV.   True  46 67.6 227 82.5 
 
Genital warts are caused by the  
herpes virus.     False  28 41.1  88 32.0  
 
Pap smears will almost always detect HPV.  True  24 35.2  95 34.5 
 
There is a vaccine to prevent HPV  
Infection that is available for women. True  26 38.2 230 83.6 
 
Having one type of HPV means that you  
cannot acquire new types.    False  45 66.1 220 80.0 
 
People can transmit HPV to their  
partner(s) even if they have no symptoms  
of HPV.      True  57 83.8 257 93.4 
 
HPV can cause cancer of the penis  
or anus (rear end) in men.    True  52 76.4 214 77.8 
 
HPV can cause oral cancer in women. True  42 61.7 205 74.5 
 
There is a vaccine to prevent HPV 
 infection that is available for men.   True    9 13.2   78 28.3 
 
 Having multiple sexual partners increases 
 a person’s risk of getting HPV.  True  61 89.7 255 92.7 
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Note. HPV = Human Papillomavirus. HPV knowledge: Number (percent) answering 
correctly. 
 
A multivariate analysis of variance (MANOVA) was used to assess the constructs 
of the Health Belief Model. The MANOVA was employed to test if women have higher 
perceived susceptibility to HPV, higher perceived seriousness of HPV, higher perceived 
benefits of HPV vaccine, greater self-efficacy to get the vaccine, and fewer perceived 
barriers to vaccination when compared to men. 
There was a statistically significant difference between males and females on the 
combined dependent variables, F(5, 322) =3.67, p=.003; Wilks’ Lambda=.95; partial eta 
squared=.05. When the results for the dependent variables were considered separately, 
the only difference to reach statistical significance, using an alpha level of .05, was self-
efficacy, F(1, 326) = 11.36, p=.001; partial eta squared = .03. An inspection of the mean 
scores indicated that females reported slightly higher levels of self-efficacy (M = 5.38, 
SD = .86) when compared to males (M = 4.98, SD = 1.07). See Table 6 for HBM items 
and mean/SD responding correctly by gender. 
Due to the unequal group sample sizes, multiple Mann-Whitney tests were used to 
test the mean rank differences between men and women on the Health Belief Model 
variables of perceived susceptibility to HPV, higher perceived seriousness of HPV, 
higher perceived benefits of HPV vaccine, greater self-efficacy to get the vaccine, and 
fewer perceived barriers to vaccination. The results of the Mann-Whitney tests showed a 
significant difference in self-efficacy among women (Md = 6.00, n= 264) and men (Md = 
5.00, n= 65), U = 6163.00, z = -3.745, p = .000. 
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Table 6. 
Means and Standard Deviations for Perceived Susceptibility, Perceived Seriousness,  
Perceived Benefits, Perceived Barriers, and Self-Efficacy as a Function of Gender  
                                        
  Perceived Perceived Perceived Perceived Self-efficacy 
  susceptibility seriousness benefits barriers 
Group     n M SD M SD M SD M SD M SD  
 
Women  263 1.98 1.10 3.20 1.35 4.60 1.02 4.07 2.24 5.38   .86  
Men         65 1.71   .95 3.21 1.36 4.40 1.15 4.63 2.17 4.95 1.07  
 
 
An independent samples t-test was conducted to determine if women expressed 
greater intention to accept the HPV vaccination when compared to men. There was a 
statistically significant difference in scores for males (M = 3.80, SD = 1.40) and females 
(M = 4.37, SD = 1.39), t(321) = 2.88, p = .002, one-tailed). This indicates that females 
have greater intention to accept the HPV vaccination than their male counterparts. 
Due to the unequal group sample sizes, a Mann-Whitney U Test was also 
conducted. The Mann-Whitney U Test revealed a significant difference in intention to 
accept the HPV vaccination. The results of the Mann-Whitney test show a significant 
difference in intention to accept the HPV vaccination among males (Md = 3.80, n = 63) 
and females (Md = 4.60, n = 260), U = 6120.50, z =- 3.12, p =. 002. 
Research Question 3 
Is there is an educational level(freshman/sophomore and junior/senior) difference 
related to knowledge, contributing factors of the Health Belief Model (perceived 
susceptibility to HPV, perceived seriousness of HPV, perceived benefits of vaccination, 
perceived barriers to vaccination, and self-efficacy) and one’s acceptance of the HPV 
vaccine among African American young adults?  
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Hypothesis 3 
 Is there an educational level (freshman/sophomore and junior/senior) difference 
related to knowledge, contributing factors within the Health Belief Model (perceived 
susceptibility, perceived seriousness, perceived benefits, perceived barriers, and self-
efficacy) and one’s acceptance of the HPV vaccine among African American young 
adults. 
An independent samples t-test was conducted to see if there was a difference in 
knowledge regarding HPV between lower and upper division college students. There was 
not a statistically significant difference in scores for lower division students (M = 11.59, 
SD = 3.15) and upper division students (M = 11.30, SD = 3.52), t(317) = .751, p = .05, 
two-tailed). This indicates that there was no significant difference in knowledge 
regarding HPV among freshman/sophomore and junior/senior grade levels. See Table 7 
for HPV knowledge items and percent responding correctly by gender. 
Table 7. 
HPV Knowledge Responses of Freshman/Sophomore and Junior/Senior African 
American College Students 
 
       Freshman/Sophomore Junior/Senior 
                  (n=151) (n=176) 
      Correct 
Items      Answer n % n %  
 
 
Most people with genital HPV have 
 no visible signs or symptoms.  True  130 88.4 152 88.4 
 
HPV can cause herpes.   False    66 44.9   78 45.3 
 
Genital warts are caused by HPV.  True    92 62.6 109 63.4 
 
HPV can cause cervical cancer in women. True  137 93.2 161 93.6 
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HPV can cause oral cancer in men.   True  109 74.1 109 63.4  
 
HPV can cause anal (rear end) cancer  
 in women.      True  111 75.5  121 70.3 
 
If a woman’s Pap smear is normal,  
she does not have HPV.   False    94 63.9   92 53.5 
 
An abnormal Pap smear may indicate  
that a woman has HPV.   True  115 78.2 137 79.7 
 
Genital warts are caused by the  
herpes virus.     False    93 63.3 119 69.2  
 
Pap smears will almost always detect HPV.  True    56 38.1   70 40.7 
 
There is a vaccine to prevent HPV  
infection that is available for women. True  114 75.5 125 72.7 
 
Having one type of HPV means that you  
cannot acquire new types.    False    32 21.8   44 25.6 
 
People can transmit HPV to their  
partner(s) even if they have no symptoms  
of HPV.      True  133 90.5 158 91.9 
 
HPV can cause cancer of the penis  
or anus (rear end) in men.    True  113 76.9 113 65.7 
 
HPV can cause oral cancer in women. True  108 73.5 121 70.3 
 
There is a vaccine to prevent HPV 
 infection that is available for men.   True    48 32.6   35 20.3   
 
 Having multiple sexual partners increases 
 a person’s risk of getting HPV.  True  134 91.2 159 92.4 
 
Note. HPV = Human Papillomavirus. HPV knowledge: Number (percent) answering 
correctly. 
 
A multivariate analysis of variance (MANOVA) was used to assess the constructs 
of the Health Belief Model. The MANOVA was employed to test if there is a difference 
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in perceived susceptibility to HPV, perceived seriousness of HPV, perceived benefits of 
HPV vaccine, self-efficacy to get the vaccine, and fewer perceived barriers to vaccination 
among freshman/sophomore and junior/senior educational level college students. There 
was no significant difference between freshman/sophomore and junior/senior education 
level college students on the combined dependent variables, F(5, 298) =1.09, p=.362; 
Wilks’ Lambda=.98; partial eta squared=.01.  
An independent samples t-test was conducted to see if there was a difference in 
intention to receive the HPV vaccination among freshman/sophomore and junior/senior 
education level college students. There was a significant difference in scores for lower 
division students (M = 4.47, SD = 1.31) and upper division students (M = 4.03, SD = 
1.45), t(297) = 2.78, p = .05, two-tailed). This indicates that there was a significant 
difference in intention to receive the HPV vaccination among freshman/sophomore and 
junior/senior education level college students. This suggests that freshman and 
sophomores have greater intention to receive the HPV vaccination than junior and senior 
education level college students. 
Research Question 4 
Is there is a relationship between traditional masculinity ideology and intention to 
receive the HPV vaccine?  
Hypothesis 4 
African American young adults with higher traditional masculinity ideology will 
be less likely to accept the HPV vaccine. 
The relationship between total traditional masculinity ideology (as measured by 
the MRNI-R) and intention to receive the HPV vaccine was investigated using Pearson 
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product- moment correlation coefficient. Preliminary analyses were performed to ensure 
no violation of the assumptions of normality, linearity and homoscedasticity. There was a 
small negative correlation between the two variables, r (319) = -.125, p =<.05. This 
correlation supported the hypotheses that young African American adults with higher 
traditional masculinity ideology were less likely to accept the HPV vaccine.   
 
The purpose of this study was to gain a better understanding of what African  
 
American young adults know about the Human Papillomavirus, the HPV vaccine and  
 
contributing factors of HPV vaccine acceptance. Constructs of the Health Belief Model  
 
were used as the theoretical framework which examined perceived susceptibility,  
 
perceived severity, perceived barriers, perceived benefits, and self-efficacy in relation to  
 
HPV vaccine intention. The concept of masculinity ideology in relation to HPV vaccine  
 
acceptance was also examined. The Attitudes towards Human Papillomavirus (HPV)  
 
and HPV Vaccination Survey and the Male Role Norms Inventory-Revised were the  
 
instruments used to measure the concepts of interest. The information garnered through 
the study questionnaires provided rich data on what African American young adults know 
and believe regarding the HPV and HPV vaccination. 
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CHAPTER FIVE: DISCUSSION 
This chapter will discuss the study findings presented in Chapter IV. Additionally, 
limitations of the study will be reviewed and implications for social work practice, policy 
and future research will be presented. 
 The current study is one of the first to examine HPV and HPV vaccination 
knowledge and awareness among college students since the FDA approval of Gardasil® 
for males aged 9 through 26 years old for the prevention of genital warts. African 
American college students have been included in prior studies regarding knowledge and 
awareness of HPV and the HPV vaccine. However, the inclusion rates have been 
minuscule in comparison to White respondents (Daley et al., 2010; Dillard & Spear, 
2010; Gerend & Barley, 2009; Licht et al, 2010; (Sandfort & Pleasant, 2010)). This study 
is one of a few with a large sample of African American respondents. Furthermore, men 
have not been the primary focus of HPV related research until very recently. This study is 
one of a few to include men in the sample, particularly African American men. 
Geographically, Missouri residents have not been included in HPV-related study 
recruitment efforts. To the authors’ awareness, only one study examining HPV and HPV 
vaccination has been conducted in the state of Missouri. This study assessed the intent 
and concerns of HPV vaccination among African-American parents and guardians of 
girls ages 9 to 17 (Sanders Thompson, Arnold, & Notaro, 2012). Interestingly, the 
influence of physician recommendation was found to be a recurring theme on parent’s 
intention to obtain HPV vaccination for their daughters. Although physician 
recommendation was not specifically examined in the current study, most college 
students noted that they received most of their HPV information from a physician.  
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Overall, most of the studies in the literature review found that there is generally a 
low awareness of HPV and HPV vaccine among college students. HPV awareness begins 
to increase with studies conducted a few years after the approval and marketing efforts of 
the HPV vaccination (Caron et al., 2008; Gerend & Barley, 2009). The current research 
study is similar to this upward trend in HPV awareness with college students, including 
African American college students ((Bynum, Brandt, Friedman, Annang, & Tanner, 
2011; Gelman, Nikolajski, Schwarz, & Borrero, 2011; Gerend & Shepherd, 2011). 
However, increased awareness of HPV does not always equate to an increase in HPV and 
HPV vaccination knowledge. 
HPV research conducted prior to HPV vaccination approval found that overall 
HPV knowledge to be low among college students (Vail-smith & Durham, 1992; Yacobi 
et al., 1999).  More recent studies found that young adults in general are becoming more 
aware of HPV and the HPV vaccine, however, their understanding and comprehension of 
key issues, such as transmission, remains low (Dillard et al., 2010; Gerend & Magloire, 
2008; Licht et al., 2009; Sandfort & Pleasant, 2009). The majority of young adults in the 
current study stated that they had heard about HPV. Yet, the mean total knowledge score 
was only 11.48(SD=3.29) out of 17 possible points. There have been studies that 
suggested greater knowledge of HPV is indicative of greater HPV vaccine acceptance 
(Jones & Cook, 2008; Woodhall et al., 2007). Studies report an increase in overall HPV 
knowledge level of college populations (Bendik, Mayo, & Parker, 2011; Dillard & Spear, 
2010). Yet, recent studies conducted with African American young adults continue to 
show lower levels of HPV and HPV vaccination knowledge among African American 
young adults’ when compared to White populations (Bynum et al., 2011; Ford, 2011; 
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Gelman et al., 2011). The results of the current study indicate that women expressed 
more knowledge regarding HPV and HPV vaccination, and greater intention to accept the 
HPV vaccination when compared to men. However, intention and acceptance do not 
always translate over to actual HPV vaccination uptake. A recent study found that 
although 80% of non-Hispanic Black women between the ages of 18-24 years were 
aware of HPV, only 8% of actually received the HPV vaccine (Ford, 2011). In a study 
examining the actual use of the HPV vaccine with college students, African American 
women were less likely to be vaccinated when compared to White women (Licht et al., 
2010). Data reporting HPV vaccine uptake for young men between the ages of 18-26, in 
the United States is are lacking. However, there has been one published report on 
adolescent male HPV vaccine uptake reported one year after the FDA approved the 
vaccine for males. As of 2010, only 2% of adolescent males have received at least one 
dose of the HPV vaccine (Reiter, McRee, Kadis, & Brewer, 2011). 
Since its approval, Gardasil® has been heavily promoted in the media. It is 
possible that young adults in this sample have become familiar with the term “HPV” 
through the “one less” commercials on television or seeing an HPV vaccine ad in a 
magazine. However, the advertisements do not fully describe or discuss the sexual 
transmission of HPV, HPV-related cancers (besides cervical cancer), the HPV 
relationship with genital warts, or the male factor with HPV. This discrepancy may 
account for a slight increase in awareness of HPV, yet very little knowledge regarding the 
details of HPV and the HPV vaccine; such as the transient nature of HPV between men 
and women. Additionally, most young adults in this study stated that they received HPV 
information from their healthcare provider. This was a disconcerting finding considering 
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the low knowledge scores of participants. The origin of this disconnect may be due to 
miscommunication or low health literacy and comprehension of HPV information during 
physician or healthcare visits with this population. Further discussion of this relationship 
is beyond the scope of this study.  
One purpose of this study was to explore the constructs of the Health Belief 
Model and how they may contribute to ones intention to receive the HPV vaccination. It 
was hypothesized that higher perceived susceptibility to HPV, higher perceived 
seriousness of HPV, greater perceived benefits of the HPV vaccine, and greater self-
efficacy would result in an increased likelihood of intention to get the HPV vaccine. 
When the HBM variables were included in the model, perceived susceptibility, perceived 
benefits and perceived barriers were found to be unique significant predictors of intention 
to get the HPV vaccination. 
HPV intention to vaccinate was uniquely predicted by the health belief of 
perceived susceptibility to HPV infection. As stated in the Health Belief Model, if 
African American young adults believe that they are more susceptible or at risk of 
contracting the HPV infection, then they are more likely to intend to protect themselves 
against transmission with the HPV vaccine. This finding indicates that sexual health 
education programs and HPV vaccine promotion efforts should focus on those risky 
behaviors that impact the self in order to increase HPV vaccination rates. In order to feel 
more at risk, an individual would have to know and understand what those risky sexual 
behaviors include and take steps to avoid those behaviors. In this study, 54% (n=148) of 
those who were sexually active did not use a condom the last time they had sex. 
Additionally, 60% (n=125) of the participants stated that they don’t always use a condom 
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to prevent STDs when having sexual intercourse with their current partner. There is an 
apparent disconnect between susceptibility and risky sexual behaviors seen among the 
young adults in this study. 
Perceived benefits of HPV vaccine were also a unique predictor of intention to 
receive the HPV vaccine. In an effort for one to obtain the HPV vaccination, an African 
American young adult would have to believe that the benefits of getting the HPV 
vaccination outweigh the risks. Healthcare providers and social work practitioners should 
not only emphasize the benefits of HPV vaccination and positive sexual health outcomes, 
but also the relationship of the negative HPV-related outcomes. A thorough discussion 
about the relationship between HPV and HPV- related cancers needs to occur. The HPV 
discussion, when it occurs, is typically in relation to sex and sexual behaviors. In 
American society, the topic of sex is uncomfortable and often occurs only once during 
puberty as “the talk”. These “talks” are fraught with embarrassment and usually the 
details are not discussed.  As Americans mature into young adults, they may feel 
hindered to discuss sexual health for a variety of reasons; taboo, shame, religion, or 
cultural beliefs. Healthcare providers and social workers must continue the open dialogue 
regarding sexual health. Today we know that sexual behaviors can have negative 
outcomes far beyond an STD. Therefore, it is imperative that discussion about HPV and 
the HPV vaccination with African American young adults include the preventative 
benefits, such as; reducing the risk of cervical, oral, anal, penile, head and neck cancers. 
As observed in previous studies, perceived barriers among African American 
young adults were found to be a significant factor related to one’s intention to receive the 
HPV vaccine (Brewer & Fazekas, 2007; Gerend et al., 2009; Zimet, 2006). An individual 
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may feel susceptible to HPV and understand the benefit of the HPV vaccine. However, if 
the individual perceives these barriers to be great, the chances of that individual getting 
the HPV vaccine are decreased substantially.  
Similar to several studies (Chou, Krill, Horton, Barat, & Trimble, 2011; Gerend et 
al., 2009; Zimet, Mays, Winston, Kee, Dickes, & Su, 2010), concerns voiced by African 
American young adults that insurance will not cover the cost of the HPV vaccine (72%) 
and that they would have to pay a lot for the vaccine (67%) were found to be the two 
greatest perceived barriers in accepting the HPV vaccination. As found in Gerend’s study 
(2009), the potential hassle involved in receiving the HPV vaccine was also found to be a 
barrier with this population; a lot of effort to get the HPV vaccination (45% ) and if it 
takes a lot of time to get the HPV vaccination (39%). Perceived and tangible barriers, 
such as these, may hinder a young adult from accepting the HPV vaccination. However, 
this is an area where social work can intervene either in the clinic or community setting, 
to work with young adults in finding the appropriate resources needed to alleviate these 
barriers.  
Safety was also found to be a barrier for HPV vaccination acceptance. Of the 
participants, 64% (n=226) worried that the HPV vaccine is not safe. Furthermore, 41% 
(n=144) feared that they can get HPV simply from getting the HPV vaccine. The HPV 
vaccines Gardasil® and Cervarix® are noninfectious, recombinant vaccines; they 
stimulate an immune response but cannot cause HPV because they are made with 
proteins that contain only part of the virus (Wheeler, 2007). Information such as this, 
which should come from one’s health care provider or social work practitioner, may help 
an African American young adult decide to receive the HPV vaccination. 
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 Only 5% (n=17) of the African American young adults in this study stated that 
they did not perceive that a barrier would prevent them from accepting the HPV vaccine. 
It takes just one perceived barrier to influence one’s decision to get the HPV vaccine. In 
this study, only 4% (n=3) of the men and 5% (n=14) of the women reported having zero 
barriers that would prevent them from accepting the HPV vaccine. The majority of the 
participants perceived anywhere from one to nine barriers which may influence their 
decision not to get the HPV vaccine.   
The second hypothesis in this study examined gender differences among African 
American young adults and factors that may contribute to HPV vaccination intention. 
This hypothesis stated that women will have more knowledge about HPV, perceive their 
susceptibility to HPV as higher, perceive the seriousness of HPV as higher, perceived 
greater benefits of the HPV vaccine, have higher self-efficacy, perceived fewer barriers to 
vaccination, and be more likely to accept the HPV vaccination when compared to men. 
There was a statistically significant difference in HPV knowledge scores between 
young men and women. This finding is consistent with the literature (Allen et al., 2009; 
Bynum et al., 2011). On the knowledge scale, men received a mean score of 10.13 
(SD=3.87) where women scored an average of 11.81(SD=3.05). Although the overall 
knowledge scores are low, as shown in first hypothesis, it is not surprising that men 
scored lower than women regarding HPV and the HPV vaccine. First, women are seen by 
healthcare professionals on an annual basis for ‘well woman’ visits. An annual exam is 
when a woman sees a physician or nurse practitioner for an annual check-up which may 
include a pap smear. When asked “Do you know what a Pap test is?” 261 (74%) of the 
African American young adults in this study answered “yes”. However, when asked 
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“What is being tested for in a Pap test?” 34% (n=90) gave an incorrect response. Still, 
more women than men knew what the Pap test is for (81% vs. 46% respectively).  
Women have more opportunities to gain awareness and knowledge of HPV 
through their annual exam and this may explain part of the gap in knowledge. Second, 
since its approval, Gardasil has been promoted in the media targeting young women and 
girls. This is another opportunity for young women to have a heightened awareness of 
HPV and HPV vaccine. Although there have been a few magazine ads for the HPV 
vaccine that feature young boys, there has not been a mass media campaign featuring 
young boys and how HPV affects them. Third, HPV vaccines have been promoted to help 
prevent the development of cervical cancer in women. This type of communication may 
lead to men being misinformed, believing HPV to be a “woman’s health issue”. 
Although the majority of African American young adults in this study knew that 
HPV could cause cervical cancer in women, knowledge about anal and oral HPV-related 
cancers was low. The National Cancer Institute predicted that in 2012 6,230 people 
would be diagnosed with anal cancer in the United States, with 80%-90% of anal cancers 
being caused by HPV (NCI, 2012). A recent study reported that anal sex is on the rise 
among young adults, particularly those who have unprotected vaginal sex (Lescano, 
Houck, Brown, Doherty, DiClemente, Fernandez, Pugatch, Schlenger, & Silver, 2009).  
In this study, when asked if “HPV can cause cancer of the penis or anus (rear end) in 
men”, 22% (n=61) of the females and 24% (n=16) of the men did not know this was a 
true statement. When asked if “HPV can cause anal (rear end) cancer in women”, 27% 
(n=75) of the women and 26% (n=18) of the men did not know this was a true statement.  
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According to a new study, two-thirds of Americans aged 15-24 have engaged in 
oral sex (Copen, Chandra, & Martinez, 2012). It is estimated that HPV type 16 is 
responsible for up to 90% to 95% of HPV-positive oropharyngeal tumors (Marklund & 
Hammarstedt, 2011) . When respondents in this study were asked if “HPV can cause oral 
cancer in women” 25% (n=70) of the women and 38% (n=26) of the men did not know 
this was a true statement. When asked if HPV can cause oral cancer in men, 31% (n=85) 
and 40% (n=27) of the women and men respectively did not know this was a true 
statement. In a recent study conducted by the American College Health Association 
(2010) only 5% of students who had engaged in oral sex over the past 30 days, had used a 
condom mostly or always during oral sex. As seen in prior research (Stone, 2006), young 
adults in this study did not know that STDs, such as HPV, can be transmitted through oral 
and anal sex. However, more African American young women than men in this study 
knew the transmission issues of HPV-related oral cancer. 
The first HPV vaccine, Gardasil®,   has been promoted in the media since its 
FDA approval for young women in 2006. However, among the respondents in this study, 
16% (n=45) of the women and 62% (n=42) of the men did not know there was an HPV 
vaccine for women. Gardasil® for young men gained FDA approval in 2009. Yet, 72% 
(n = 197) of the women and 87 % (n=59) of the men in this study did not know there was 
an HPV vaccine for young men. Although more young women than men knew about the 
available HPV vaccination for women, there remain a large number of young adults in 
this study who are unaware of this type of HPV protection for young men. Most college 
students are required to have a physical exam prior to the start of the school year. 
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Students in this study report getting their HPV information from physicians, yet the 
majority of students did not know about the availability of an HPV vaccine for men.  
When gender differences were examined utilizing the constructs of the Health 
Belief Model, self-efficacy was found to be statistically significant. Young adult women 
in this study seem to have a stronger sense of self efficacy in their ability to receive the 
HPV vaccine when compared to men. There were no significant gender differences 
related to the HBM variables of perceived susceptibility, perceived seriousness, perceived 
benefits, and perceived barriers. However, as shown in the first hypothesis, perceived 
susceptibility, perceived benefits and perceived barriers were significant factors in one’s 
intention to vaccinate. It appears as though, within the realm of culture, African 
American young men and women are congruent, except with self-efficacy, in their 
perceptions regarding these health beliefs and their intention to receive the HPV vaccine. 
There was a statistically significant gender difference related to one’s intention to 
receive the HPV vaccination. Consistent with prior research studies, young women in this 
study were more likely to intend to receive the HPV vaccination than young men (Jones 
& Cook, 2008). One explanation for this difference could be the fact that the HPV 
vaccine was approved for young women a few years prior to the approval for young men. 
Second, there has been a great deal of media regarding women, HPV, HPV vaccination 
and cervical cancer.  
To date, studies examining HPV and HPV vaccination among college students  
only looked at the aggregate of students as compared with education level. The 
sociodemographic variable of education level may have a contributing factor in one’s 
acceptance of the HPV vaccination. The third hypothesis in this study looked at the 
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differences between freshman/sophomore and junior/senior educational level differences 
in HPV knowledge, Health Belief Model variables (perceived susceptibility, perceived 
seriousness, perceived benefits, perceived barriers, and self-efficacy) and acceptance of 
the HPV vaccination. Although the results indicate no significant differences between the 
groups on most items, there was a difference in one’s intention to receive the HPV 
vaccination. Freshman/sophomore African American college students expressed greater 
intention to receive the HPV vaccination. This finding has important implications for 
health educators when developing sexual health education programs. This is a time when 
college students are first exposed to the freedoms of what the college environment offers, 
such as; access to alcohol, drugs and sexual experimentation. Educational interventions 
aimed at increasing HPV knowledge and HPV vaccination uptake would be most 
beneficial to incoming freshman/sophomore students.  
Results from the fourth hypothesis indicate that African American young adults 
with higher traditional masculinity ideology will be less likely to intend to receive the 
HPV vaccine. The findings from this study coincided with prior research with African 
American male participants examining masculinity ideology and health behaviors 
(Courtenay, 1998; Hammond, Matthews, Mohottige, Agyemang, & Corbie-Smith, 2010; 
Mahalik, Lagan, & Morrison, 2006). In his 2008 study, Wade found that men who 
endorse traditional masculinity are less likely to engage in health-promoting behaviors 
and have greater health risks than men who do not endorse traditional masculinity. As in 
Wade’s study (2008), similar results were found in the current study of both men and 
women. Young African American adults in this study endorsed traditional masculinity 
ideology, yet they engaged in risky sexual health behaviors considered risky for 
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contracting an STD, such as; having sexual intercourse without using a condom one 
hundred percent of the time and having sex with multiple partners. With regard to Black 
sexuality, West (1993) stated that the lack of opportunity to acquire power in traditional 
patriarchal structures compels some Black men to adopt a “Black machismo identity that 
solicits primarily sexual encounters with women” (p.89) and reinforces the myth of Black 
male sexual prowess. These underlying cultural norms, beliefs and myths surrounding 
masculinity may continue to be exhibited in the college environment with African 
American young adults. 
 As Bowleg described in her study entitled Love, Sex, and Masculinity (2004), the 
lives of African American men and women are inextricably linked historically and 
socioculturally. Culturally speaking, the traditional masculinity ideology that holds true 
for African American men may also hold true for African American women as well. 
Bowleg further states that African American men’s relationships and sexuality are not 
isolated from the poverty and racism that are hallmarks for many African American men. 
In the context of this study, African American men’s STD risk behavior (particularly 
having sex at an early age, having multiple sex partners and having unprotected sex) form 
a leading exposure for African American women’s HPV risk. 
  Wolfe (2003) described the role of hypermasculinity in African American males. 
He described how men tend to adopt a manipulative and exploitive attitude with African 
American women. Further stating how men try to “get over” which means to overcome a 
young African American woman’s sexual defenses, and of their “quest for sexual 
prowess” (p. 848). Furthermore, Wolfe stated that the elements of hypermasculine 
personality are a callous sexual attitude towards women, and a belief that violence is 
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manly. These attitudes and high risk sexual behaviors of young men have a great impact 
on young women. Doss & Hopkins, (1998) stated that male role norms are culturally 
constructed expectations, considered appropriate for men and that these norms are 
determined by both men and women in the culture. In relation to traditional masculinity 
ideology, African American men and women share in the cultural milieu of 
hypermasculinity. This dynamic may have an effect on the risky sexual health behaviors 
of African American young adults, as observed in this study.  
 The limited research on traditional masculinity with African Americans and 
health behaviors, such as HPV vaccination, suggests that traditional masculinity ideology 
supports those health-related attitudes that put men and women at risk for poor health. In 
relation to the current study, traditional masculinity ideology may be a contributing factor 
in an African American young adult’s decision to accept the HPV vaccination. Results 
from this study found that there was a lower intention to vaccinate when scores on 
traditional masculinity ideology increased.  
Implications for Policy, Practice and Future Research 
Policy Implications.  On March 23, 2010, the Affordable Care Act (ACA) was 
passed by Congress and signed into law by President Obama (HealthCare.gov, 2012).  
According to the ACA, young adults can now remain on their parents’ insurance plan 
until the age of 26, which coincides with the current HPV vaccination age guideline.   
What happens to African American young adults who are over the age of 18 and do not 
have health insurance? The answer to this question varies by state and by the organization 
that provides the HPV vaccine. In Missouri, Planned Parenthood will provide the HPV 
vaccine for $135 per injection (Planned Parenthood, 2012) and Walgreens will charge 
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$215 for the first HPV vaccine shot and $185.00 each for the 2nd and 3rd shots 
(Walgreens, 2013). An adult who does not have insurance or whose insurance may not 
cover the HPV vaccine may qualify for the Merck Vaccine Patient Assistance Program 
(MVPAP) ("MVPA," 2012). Gardasil® is part of this program which is funded by Merck 
& Co., Inc. Eligibility criteria include being over the age of 18, without health insurance 
or meeting the annual household income levels ("Gardasil HPV vaccine," 2007). For 
young adults enrolled in a college or university, the cost is usually not covered by the 
school’s health insurance plans. When offered, the cost of each injection varies at each 
school, for example: $155.00 per injection (University of Missouri-Columbia). Although 
the ACA is a great improvement in policy when it comes to preventative healthcare, 
particularly sexual health, there is still work to be done to make the vaccine financially 
accessible to all young adults.  Findings from this study show that cost is a barrier to ones 
intention to receive the HPV vaccination. As client advocates, social workers can utilize 
information from this study to work to change policies regarding HPV vaccination, such 
as mandatory vaccination. Mandating HPV vaccination would lower cost and provide 
access to all young adults who would like to receive the HPV vaccination. 
Practice Implications. Findings from this study indicate that knowledge regarding 
HPV and HPV vaccination is limited. Therefore, it is necessary to develop HPV related 
educational opportunities for African American college students, particularly those 
attending college or university in Missouri. Social workers in healthcare settings can 
utilize knowledge gained from this study to inform students of the prevalence, 
transmission and negative outcomes related to HPV. Although this study examined a 
specific population, it is imperative that all students receive the most current HPV and 
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HPV vaccination information. A general information session focused on HPV could be 
given by  social workers during freshman orientation, followed by an information session 
specifically for African Americans at the minority student orientation. The information 
sessions could emphasize the findings from this study to include: 1) Increasing health 
literacy by insuring that the students understand the sexual health behaviors that put both 
men and women at risk for transmitting the HPV, 2) Informing students of the safety and 
efficacy of the HPV vaccine, 3) Discussing how masculinity ideology within the African 
American culture and the negative affect it may have on one’s sexual health behavior, 
and 4) Directing students about where and how to receive financial assistance to pay the 
series of three HPV vaccinations.  
College freshmen are often overwhelmed with information, while at the same 
time trying to adjust to the college environment. Social workers in public health settings 
could partner with colleges to implement several avenues of HPV information 
reinforcement such as; sexual health information brown bag seminars, monthly HPV 
newsletter through student e-mail or text messaging bullet point information. The 
reinforcement techniques could be applied to African American students throughout their 
tenure at college or university. 
Community social workers can have a great impact on educating African 
American young adults throughout the State of Missouri. Community social work is 
deeply rooted in the history of social work. A community social worker in Missouri could 
partner with local health clinics to develop a program, with measurable outcomes, that is 
focused on HPV and HPV vaccination. To the researcher’s knowledge, there has not been 
a community level intervention specifically aimed at HPV and HPV vaccination noted in 
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the literature or in the State of Missouri. Measurable outcomes of an HPV and HPV 
vaccination program may include 1) increased HPV awareness, knowledge and 
comprehension, 2) behavior change (increased condom use and annual well person 
visits), 3) decreased HPV incidence, and 4) increased HPV vaccination uptake. In 
addition to an initial community needs assessment, the knowledge garnered from this 
study regarding HPV and HPV vaccination awareness, knowledge, sexual behaviors 
could serve as the basis for program and survey development.  
The next steps would be to identify the target audience within the African 
American community, which may include parents, young adults, community leaders, 
spiritual care leaders, physicians and programs that support the initiative (i.e., Planned 
Parenthood). Social workers could train peer educators who self-identify with the target 
audience to facilitate the program. The program could be presented at various locations 
within the community, such as; schools, community centers, libraries, and YMCA or 
YWCA. Social workers can develop educational materials that the community members 
could take with them, which may include; safer sex information (with condoms), HPV 
and HPV vaccination information, tips on how to discuss safer sex methods, HPV and 
HPV vaccination with your parent, children and partner, and how to access financial and 
informational resources in the community. A support group could be formed to include 
those who have experienced HPV, as well as, those who are concerned about their sexual 
health behaviors. Additionally, community social workers could establish relationships 
with media outlets that are geared specifically towards the African American community. 
African American specific media outlets may include African American radio stations 
(e.g., Magic 100.3 which is broadcast in several Missouri communities), newspapers 
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(e.g., Saint Louis American) or community events such as the “Sista Strut” which holds 
an annual race to bring breast cancer awareness to the African American community in 
Missouri. 
Future Research. Social work researchers are in an opportune position to 
continue the study of HPV and HPV vaccination among African American young adults, 
as well as adolescents.  First, a valid and reliable HPV and HPV vaccination intention 
instrument for use with young men and women is needed in this field of research. This 
study utilized a modified version of one of the first instruments developed to assess HPV 
knowledge and HPV vaccine acceptance.  
This study did not specify whether a respondent had initiated or completed the 
HPV vaccination. In studies included in this literature review, only a few assessed HPV 
vaccination status and still fewer included African American young adults in their 
assessment. Future research in this area should include current HPV vaccination status in 
an effort to compare knowledge, sexual health behaviors and beliefs among African 
American young adults.  
Future research should involve the general population of African American young 
adults. Participants in this study were all in attendance at a public college or university. 
College students are at an advantage in that they have a certain level of access to 
healthcare that the general population does not have. Furthermore, HPV knowledge, 
health beliefs and behaviors of the general population of African Americans in Missouri 
may look quite different from African American college and university students.  
There is a dearth of literature focusing on sexual minority youth, particularly 
African American young adults, in relation to HPV and the HPV vaccine. Although most 
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of the early HPV research focused on men who have sex with men (MSM), to date, HPV 
and HPV vaccine related research with a specific focus on lesbian and bi-sexual African 
American young adults is virtually nonexistent. Sexual minority young adults may feel 
social stigma which may lead to avoidance of a physician visit. This, in turn, had a 
tremendous effect on their current sexual health status and opportunities to learn about 
issues such as HPV and the HPV vaccination. Bisexual and lesbian women, in particular, 
may have the misconception that they are not vulnerable to STD’s including HPV. 
However, lesbian and bisexual women can transmit HPV through genital skin-on-skin 
contact.  
Additionally, in African American culture, there is a well-known slang described 
as, “being on the down-low”.   This refers to a subset of African American men who 
discreetly have sex with other men while being in a sexual relationship with women. 
Typically men on the down-low do not consider themselves as homosexual or bisexual, 
which may speak to traditional masculinity ideology of African Americans. Yet, young 
African American men on the “down-low” are putting their significant other in jeopardy 
of contracting an STI, such as HPV.  HPV research involving African American sexual 
minority young adults may lead to an understanding of the current state of awareness and 
knowledge which in turn can help to develop appropriate HPV vaccine acceptance 
interventions.  
It was evident from this study that African American men and women are 
engaging in sexual activities at an early age, prior to entering college or university. It is 
imperative that research focus on African American adolescents and their parent or 
guardian in an effort to increase awareness and knowledge of HPV and HPV vaccination 
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opportunities for their children. Although parents and adolescents were not included in 
this study, early adolescence is a period in life where norms, values and beliefs are 
shaped. Having an impact on sexual health and behaviors at an early age, will lead to a 
more knowledgeable and informed young adult. Conducting educational interventions 
with parents and adolescents on HPV and HPV vaccination early will help young African 
American adults in college to make positive sexual health behavior decisions, especially 
regarding the decision to accept the HPV vaccination. 
To the researcher’s knowledge, this was the first study to include masculinity 
ideology in relation to HPV vaccination acceptance. Future research should continue to 
focus on the cultural aspects of African American young adults’ masculinity ideology in 
an effort to capture their decision making regarding sexual health behaviors in the realm 
of interpersonal relationships. This study touched the tip of the iceberg in relation to 
masculinity ideology and African American young adults. Similar to masculinity 
ideology literature reviewed in this study, African American young adults report a 
negative relationship with masculinity ideology and the health behaviors, particularly 
HPV vaccination. In an effort to look beneath the surface, research could look deeper at 
the underlying elements of masculinity ideology within this culture, as well as between 
genders to examine how it impacts sexual health behaviors and HPV vaccination 
acceptance decision making of African American young adults. 
The majority of studies to date have been assessments regarding knowledge and 
awareness of HPV and the HPV vaccine. Intervention studies with African Americans are 
needed to increase awareness of HPV, HPV knowledge around transmission and HPV 
vaccination. Evidence outlining best practices for successful interventions regarding HPV 
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awareness and knowledge may lead to a significant increase in HPV vaccination uptake 
among African Americans, particularly young adults. 
Lastly, to the researcher’s knowledge, there has yet to be a longitudinal 
intervention study conducted among African American young adults related to HPV and 
HPV knowledge, behavior and vaccination uptake. This type of research design would 
contribute greatly to the current body of literature particularly with the relatively new 
FDA HPV vaccine approval and guidelines for young men, the HPV-related cancer 
developments and the Affordable Care Act.  
Limitations 
There are several limitations to consider with the current research study. First, the 
study involved recruitment of a non-probability sample of African American students 
from ten public colleges and universities in the state of Missouri. Those who participated 
in the study may have had a higher interest in HPV or the HPV vaccine than those who 
did not participate. Second, the study employed a self-reporting survey methodology. 
Self-report is a required element for full disclosure on the sensitive nature of sexual 
health knowledge and behavior. However, self-report lends itself to recall bias and social 
desirability (Paulhus & Reid, 1991). Third, the population of interest is of African 
American college age men and women. Although the vaccine is approved for young 
adults between the ages of 18-26, the results cannot be generalized to all African 
American of this age or those who are not in the public college or university system.  
Results cannot be generalized beyond the young men and women involved in this 
study. Masculinity ideology is a multidimensional concept; this study was limited in that 
it examined one aspect of traditional masculinity ideology and not the sub-parts or 
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nuances of the entire concept. Lastly, the instrument was modified from a survey which 
was limited in reliability and validity. Future HPV related research would benefit from an 
instrument that was psychometrically sound. 
Conclusions 
 One of the goals of Healthy People 2020 is to promote healthy sexual behaviors, 
strengthen community capacity, and increase access to quality services to prevent 
sexually transmitted diseases (STDs) and their complications ("Healthy People 2020," 
2012; HealthyPeople.gov, 2012). One of the specific objectives of Healthy People 2020 
is to reduce the proportion of females with Human Papillomavirus (HPV) infection. To 
accomplish this goal we must educate men and women on HPV and HPV vaccination 
resources and to address the identified barriers to getting vaccinated. The historical roots 
of the social work profession are grounded in a philosophy of prevention (McCave & 
Rishel, 2011, p. 226). Social workers often lead prevention and health promotion efforts 
in fields such as HIV/AIDS and gerontology. It is time that social workers and public 
health social work researchers take the lead in research, prevention and health promotion 
in the area of HPV and HPV vaccination. 
Empirically, we know very little about the knowledge level and attitudes 
regarding HPV and HPV vaccination among African American young adults. However, 
given the strengths of this study, there are conclusions which can be extrapolated from 
the study results. This study found significant relationships between the perceived 
barriers, perceived benefits, perceived susceptibility, self-efficacy, educational level 
differences and knowledge in relation to HPV vaccine acceptance. Findings from this 
study suggest a high level of HPV awareness, yet a mid level range of knowledge 
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regarding modes of transmission of HPV, HPV related cancers and the HPV vaccination 
among African American young adults. This study highlights the fact that young adult 
African American college students living in Missouri exhibit high levels of risky sexual 
behaviors, such as having sex at a very early age and inconsistent use of condoms. With 
the possibility of greater access to care via the Affordable Care Act, the hope is that we 
will see an increase in minority populations receiving quality healthcare. It is essential 
that physicians, nurses and social workers not only have HPV and HPV vaccine related 
knowledge themselves, but also impart this knowledge to African American young 
adults. Missouri is one of the 29 states across the country that does not mandate 
comprehensive sex education to inform public school students about reproductive health, 
including sexually transmitted diseases. Furthermore, when school districts voluntarily 
include a sex education program, they are required to use an abstinence-only program. If 
a school chooses to provide additional education on sexuality it must “present abstinence 
from sexual activity as the preferred choice of behavior in relation to all sexual activity” 
("Missouri statutes on sex education," 2012). Armed with the findings of the current 
study, social workers can have an influence on policy related to the sexual education 
content that is permissible in public schools in Missouri. 
These are important findings if the objective is to increase HPV awareness, 
knowledge, and ultimately HPV vaccine uptake. It is vital to include African American 
young adults in research pertaining to HPV and cancer prevention research. It is through 
this work that social workers can ensure that culturally specific barriers are identified, 
health disparities are addressed and appropriate interventions are implemented. HPV 
related research within the African American population is needed to further advance the 
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development of knowledge and inform social work practice, behavior therapy, 
counseling, clinical practice, community practice, as well as the evaluation of social 
policies. 
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APPENDIX A 
 
Dear Saint Louis Community College Student, 
 
I would like to invite you to participate in my dissertation research study. The purpose of 
my study is to gain a better understanding of what we, young African American men and 
women, know about the Human Papillomavirus (HPV) and what factors may contribute 
to HPV vaccine acceptance. 
 
I am conducting a survey of African American men and women currently attending 
Florrisant Valley, Forest Park, Meramec, and Wildwood Community Colleges. Your 
input can help me understand what African American college students in the Saint Louis 
area know about the Human Papillomavirus, the HPV vaccine and how masculinity 
ideology plays a role in our health behaviors. Your participation will have a great effect 
on our future health, particularly regarding the availability of the HPV vaccine for all 
young African American men and women. 
 
 It will take you approximately 15 minutes to complete the survey. After completing the 
survey, you will have an opportunity to win one of several $25 gift cards. 
Simply click on the link below to participate in this study: 
 
Survey link 
 
I would appreciate your response by Deadline 
Your input is very important to me and will be kept strictly confidential. 
If you have any questions please do not hesitate to contact me. 
 
Sincerely, 
 
Jennifer A. Sledge, PhD(c), MSW 
University of Missouri 
314.454.8573 
jasm28@missouri.edu 
 
If you experience technical difficulties accessing or submitting the survey please contact 
_______ at _______. 
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APPENDIX B 
WAIVER OF DOCUMENTATION OF CONSENT 
 
INVESTIGATOR’S NAME: JENNIFER A. SLEDGE, PHD(C), MSW 
PROJECT # 1162697 
DATE OF PROJECT APPROVAL:  
 
FOR HS IRB USE ONLY 
APPROVED  
 
 
_________________________________
_______________ 
HS IRB Authorized Representative                          
Date 
 
EXPIRATION DATE:   
__________________________ 
 
 
STUDY TITLE:  
Contributing factors related to Human Papillomavirus (HPV) vaccine 
acceptance among African American young adults. 
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You are being asked to participate in a research study. The purpose of this 
research is to gain a better understanding of what young African American men and 
women know about the Human Papillomavirus (HPV) and the HPV vaccine. I, as an 
African American, understand that disparities in healthcare exist against African 
Americans. I am interested in if or how that is happening with the Human Papillomavirus 
vaccine. 
This study is being directed by Jennifer A. Sledge, MSW, a social work doctoral 
candidate, under the supervision of Dr. Colleen Galambos, School of Social Work, 
University of Missouri-Columbia. 
By agreeing to participate, I understand that: 
a. The purpose of this study is to gain a better understanding of what young African 
American men and women know about the Human Papillomavirus (HPV) and 
what factors may contribute to HPV vaccine acceptance. 
 
b. My part in the research will be to share my beliefs and opinions about the Human 
Papillomavirus, the HPV vaccine, as well as, my thoughts on masculinity 
ideology. 
 
c. It may take up to 15 minutes to answer the questions. 
 
d. Participation is voluntary. I am free to stop participating at any time. 
 
e. There will be an opportunity to participate in a drawing for a $25 gift card, from 
each of the participating universities, upon completion of the survey. 
 
f. My participation in this research should not expose me to any greater risk than 
that encountered in everyday life. 
 
g. To protect my identity, this survey and demographic information are free of any 
identifying information. The survey is anonymous. 
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h. The results of this research may be published but I will not be identified in any 
such publication. All results will be reported in the aggregate (total) and they will 
be made available to the college I am currently attending.  
 
i. This study has been approved by the MU Health Sciences Institutional Review 
Board (IRB) at the University of Columbia, MO (project #1162697).  
 
j. If I have any questions regarding my rights as a participant in this research and/or 
concerns about the study, or if I feel under any pressure to enroll or to continue to 
participate in this study, I may contact the University of Missouri Health Sciences 
Institutional Review Board (which is a group of people who review the research 
studies to protect participants’ rights) at (573) 882-3181. 
 
k. If there are any additional questions, I am to contact Jennifer A. Sledge, MSW, 
Doctoral Student, 711 Clark Hall, University of Missouri School of Social Work, 
Columbia, MO  65211 or at 314.454.8573. I can also email her at 
jasm28@missouri.edu. Dr. Galambos can be reached at galambos@missouri.edu. 
 
l. Please print a copy of this Waiver of Documentation of Consent for your records. 
 
By clicking the “next” button, I am consenting to participate in this study. 
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APPENDIX C 
The Knowledge and Attitudes towards Human 
Papillomavirus (HPV) and HPV Vaccination Survey 
 
To be completed by both men and women 
 I would first like to ask you questions regarding your sexual health, the 
Human Papillomavirus (HPV) and the HPV vaccine. This survey is anonymous. We 
will not be able to connect your name with your answers. Please check your 
response as appropriate. Please be honest. 
  
1. When you have sexual intercourse with your current sexual partner(s), do you 
ever use anything to prevent pregnancy?  
 
□ Yes: If yes, what do you use?: ____________________________________________. 
□ Check here if you do not currently have a sexual partner (skip to #4). 
□ No (skip to #4). 
 
2. How often do you use this method to prevent pregnancy when you have sex 
with your current partner(s)?  
 
Almost Never              Every time  
1  2  3  4  5  6 
 
3. When you have sexual intercourse with your current sexual partner(s), do you 
ever use a condom to prevent sexually transmitted diseases (STDs)?  
 
Almost Never              Every time  
1  2  3  4  5  6 
 
No (If no, what is your primary method, please specify: ______________________. 
 
4. Did you use a condom the last time you had sex?     
 
□ No □ Yes  □ I’ve never had sex    
 
5. Do you know what a Pap test is?   
 
 Yes. If yes, what is being tested for in a Pap test? 
  HIV/AIDS 
  Abnormal cells that may develop into cervical cancer 
  Pregnancy 
  Sexually Transmitted Disease (STDs) 
No (skip to # 7). 
 Don’t know (skip to #7). 
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6. Have you or your current partner or any of your previous partners ever had an 
abnormal Pap test? 
 
No     Yes   Don’t know   Check here if you have never had a sexual partner. 
 
 
7. Have you ever heard of the STD called the Human Papillomavirus or HPV?   
   
□ Yes. If yes, where did you hear about it? (Check all that apply). 
 
Healthcare provider     Television or radio 
Friend      Family member 
Partner      Internet 
Class (health education program)   Magazine/Newspaper 
Other (please specify): ___________________________ 
 
□ No (skip to next section). 
 
  8. Which of the following puts you at risk for HPV? (Check all that apply). 
 
 Having sex at an early age    Alcohol use 
 Having frequent sex    Being under the age of 25 
 Having many sex partners    Drug use 
 Using birth control pills 
 Other (please specify):_____________________________ 
 
  
Please read the following information paragraph  
before answering the following questions 
 
The Human Papillomavirus (HPV) 
 
Genital Human Papillomavirus (HPV) is the most common sexually 
transmitted infection. HPV is contacted most often through unsafe sexual 
practices. There are more than 40 types that can infect the genital areas of males 
and females. These HPV types can also infect the mouth and throat. HPV is not 
the same as herpes or HIV (the virus that causes AIDS). Most people with HPV do 
not develop symptoms or health problems from it. In 90% of cases, the body’s 
immune system clears HPV naturally within two years; but sometimes, certain 
types of HPV can cause genital warts in men and women. Other HPV types can 
cause cervical cancer, and less common cancers such as penile (penis), anal (rear 
end), vaginal (vagina), head, neck and oral (tongue, tonsils and throat). There is no 
way to know which people who get HPV will go on to develop cancer or other 
health problems. 
The next questions ask about genital Human Papillomavirus (HPV) 
infection. Genital HPV is a sexually transmitted disease (STD). It is not the same 
as HIV, the virus that leads to AIDS.  
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Please check a number on the line next to each statement, using the 
following scale (1 = very unlikely to 6 = very likely). If you currently have or have 
had genital HPV in the past, please think about how likely it is that you’ll become 
infected again (with another type of HPV) in the future.  
 
9. How likely is it that you’ll get genital HPV in the next 10 years? 
 
 Very unlikely          Very likely   
1  2  3  4  5   6 
 
  
10. How likely do you think it is that a current or recent partner(s) of yours is 
infected with HPV?  
 
Very unlikely               Very likely   
1  2  3  4  5   6 
 
11. How likely is it that you’d test positive for genital HPV if you were tested 
today?  
 
Very unlikely               Very likely   
1  2  3  4  5   6 
 
12. How likely is it that you’ll get genital warts in the next 10 years? 
  
Very unlikely                   Very likely   
1  2  3  4  5  6 
 
 13. How likely is it that you would receive a vaccine to prevent future genital HPV 
infection if it was proven safe, effective and available?  
 
Very unlikely                       Very likely   
1  2  3  4  5  6 
 
 
 
14. If you had HPV, how severe do you think genital HPV infection would be for 
yourself?  
 
Not at all severe      somewhat severe        fairly severe     severe     very 
severe 
 
Please answer the following 2 questions as if you were told you had HPV.  
Please check one response for each of the following questions 
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15. If your partner had HPV, how severe do you think genital HPV infection would 
be for your female/male partner?  
 
Not at all severe      somewhat severe        fairly severe     severe     very 
severe 
 
 
 
 
16. Most people with genital HPV have no visible signs or symptoms. 
 
 True  False  Don’t Know  
 
17. HPV can cause herpes. 
 
 True  False  Don’t Know  
 
18. Genital warts are caused by HPV. 
 
 True  False  Don’t Know 
 
19. HPV can cause cervical cancer in women. 
 
 True  False  Don’t Know  
 
20. HPV can cause oral cancer in men.  
 
 True  False  Don’t Know 
 
21. HPV can cause anal (rear end) cancer in women.  
 
 True  False  Don’t Know 
 
22. If a woman’s Pap smear is normal, she does not have HPV. 
 
 True  False  Don’t Know 
 
23. An abnormal Pap smear may indicate that a woman has HPV. 
 
  True  False    Don’t Know  
 
24. Genital warts are caused by the herpes virus. 
 
  True  False  Don’t Know  
 
The following questions refer to the transmission, diagnosis and disease of HPV. 
Please check true, false or don’t know for the following statements about HPV 
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25. Pap smears will almost always detect HPV.  
 
 True  False  Don’t Know  
 
26. There is a vaccine to prevent HPV infection that is available for women. 
 
 True  False  Don’t Know  
 
27. Having one type of HPV means that you cannot acquire new types.  
 
 True  False  Don’t Know  
 
28. People can transmit HPV to their partner(s) even if they have no symptoms of 
HPV.  
 
 True  False  Don’t Know  
 
29. HPV can cause cancer of the penis or anus (rear end) in men.  
 
 True  False  Don’t Know  
 
30. HPV can cause oral cancer in women. 
 
 True  False  Don’t Know 
 
31. There is a vaccine to prevent HPV infection that is available for men.  
 
 True  False  Don’t Know  
 
32. Having multiple sexual partners increases a person’s risk of getting HPV. 
 
 True  False  Don’t Know  
 
 
33. The HPV vaccine will protect people from getting genital HPV. 
 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
34. The HPV vaccine will be effective in preventing genital HPV infection. 
 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
The following questions ask about the HPV vaccine.  
 132 
 
35. The HPV vaccine will reduce a man’s chances of developing HPV related 
cancers. 
 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
 
36. The benefits of getting the HPV vaccine outweigh the potential risks. 
 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
37. Getting the HPV vaccine may be a good thing to do for my health.  
  
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
38. Getting the HPV vaccine will give me peace of mind about my health. 
  
 Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
39. Many of my male friends will get vaccinated for genital HPV. 
 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
40. I am confident in my ability to find a clinic or doctor to get vaccinated. 
 
 Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
41. Whether I get vaccinated against HPV is under my personal control. 
 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
42. If I get vaccinated for HPV, people may think that I’m sexually promiscuous or 
sleep around. 
 
 Disagree Strongly        Agree 
Strongly 
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1  2  3  4  5  6 
 
43. I won’t need to get vaccinated for HPV because I’m not at risk for genital HPV. 
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
44. People tend to look down on people who have an STD.  
Disagree Strongly        Agree 
Strongly 
1  2  3  4  5  6 
 
 
45. Having to pay a lot for the vaccine. 
 
 Yes  No  
 
46. Fear that I could get HPV from getting the vaccine. 
  
 Yes  No 
 
47. Having to get shots. 
 
 Yes  No   
 
48. Fear that people might think poorly of me if I get vaccinated for HPV. 
 
 Yes  No 
 
49. Worrying that the vaccination won’t work.  
 
 Yes  No  
 
50. Worrying that the vaccine isn’t safe.  
 
 Yes  No  
 
51. If health insurance wouldn’t pay for the vaccine.  
 
 Yes  No  
Would the following factors prevent or keep you from getting vaccinated 
against genital HPV in the future? Check either yes or no. 
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52. If it took a lot of effort to get the vaccine. 
 
 Yes  No  
 
53. If it took a lot of time to get vaccinated.  
 
 Yes  No  
 
54. How likely is it that you’ll try to get more information about the HPV vaccine? 
 
Very unlikely                       Very likely   
1  2  3  4  5  6 
 
55. How likely is it that you’ll consider getting the HPV vaccine? 
 
Very unlikely                       Very likely   
1  2  3  4  5  6 
 
56. How likely is it that you’ll make it a priority to get the HPV vaccine? 
Very unlikely                       Very likely   
1  2  3  4  5  6 
 
57. How likely is it that you’ll actually get the HPV vaccine? 
Very unlikely                       Very likely   
1  2  3  4  5  6 
 
 
58. If a health care professional offered you the genital HPV vaccine within the 
next three years, how likely is it that you’d get vaccinated? 
 
Very unlikely                       Very likely   
1  2  3  4  5  6 
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MRNI-R 
Please complete the questionnaire by circling the number which indicates your level 
of agreement or disagreement with each statement. There is no right or wrong 
answer. Please give only one answer for each statement. 
 
Strongly Disagree Slightly No        Slightly Agree     Strongly 
Disagree   Disagree Opinion      Agree      Agree 
      1       2       3       4                  5                 6                7 
_______________________________________________________________________ 
 
59. Homosexuals should never marry. 
1 2 3 4 5 6 7 
 
      60. The President of the U.S. should always be a man. 
 1 2 3 4 5 6 7 
 
61. Men should be the leader in any group. 
 1 2 3 4 5 6 7 
 
      62. A man should be able to perform his job even if he is physically ill or hurt. 
 1 2 3 4 5 6 7 
 
63.  Men should not talk with a lisp because this is a sign of being gay. 
1 2 3 4 5 6 7 
 
64.  Men should not wear make-up, cover-up or bronzer.  
 1 2 3 4 5 6 7 
 
65.  Men should watch football games instead of soap operas.  
 1 2 3 4 5 6 7 
 
66. All homosexual bars should be closed down. 
1 2 3 4 5 6 7 
 
67. Men should not be interested in talk shows such as Oprah. 
 1 2 3 4 5 6 7 
 
68. Men should excel at contact sports. 
 1 2 3 4 5 6 7 
 
      69. Boys should play with action figures not dolls.  
 1 2 3 4 5 6 7 
 
70. Men should not borrow money from friends or family members. 
 1 2 3 4 5 6 7 
 
71. Men should have home improvement skills. 
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Strongly Disagree Slightly No        Slightly Agree     Strongly 
Disagree   Disagree Opinion      Agree      Agree 
      1       2       3       4                  5                 6                7 
 
  
72. Men should be able to fix most things around the house. 
 1 2 3 4 5 6 7 
 
73. A man should prefer watching action movies to reading romantic novels. 
 1 2 3 4 5 6 7 
  
74. Men should always like to have sex. 
1 2 3 4 5 6 7 
  
75. Homosexuals should not be allowed to serve in the military. 
 1 2 3 4 5 6 7 
 
76. Men should never compliment or flirt with another male. 
 1 2 3 4 5 6 7 
 
   77. Boys should prefer to play with trucks rather than dolls. 
 1 2 3 4 5 6 7 
 
78. A man should not turn down sex. 
1 2 3 4 5 6 7 
 
      79. A man should always be the boss.  
 1 2 3 4 5 6 7 
  
80. A man should provide the discipline in the family. 
 1 2 3 4 5 6 7 
 
81. Men should never hold hands or show affection toward another. 
 1 2 3 4 5 6 7 
 
82. It is ok for a man to use any and all means to “convince” a woman to have sex. 
 1 2 3 4 5 6 7 
  
83. Homosexuals should never kiss in public. 
1 2 3 4 5 6 7 
 
      84.  A man should avoid holding his wife’s purse at all times. 
 1 2 3 4 5 6 7 
      
       85. A man must be able to make his own way in the world. 
 1 2 3 4 5 6 7 
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Strongly Disagree Slightly No        Slightly Agree     Strongly 
Disagree   Disagree Opinion      Agree      Agree 
      1       2       3       4                  5                 6                7 
 
 
86. Men should always take the initiative when it comes to sex.  
 1 2 3 4 5 6 7 
 
87. A man should never count on someone else to get the job done. 
 1 2 3 4 5 6 7 
 
88. Boys should not throw baseballs like girls. 
 1 2 3 4 5 6 7 
 
89. A man should not react when other people cry. 
 1 2 3 4 5 6 7 
 
90. A man should not continue a friendship with another man if he finds out that the  
      other man is homosexual. 
 1 2 3 4 5 6 7 
 
91. Being a little down in the dumps is not a good reason for a man to act depressed. 
1 2 3 4 5 6 7 
 
92. If another man flirts with the women accompanying a man, this is a serious             
 provocation and the man should respond with aggression. 
 1 2 3 4 5 6 7 
 
93. Boys should be encouraged to find a means of demonstrating 
      physical prowess. 
 1 2 3 4 5 6 7 
 
94. A man should know how to repair his car if it should break down. 
 1 2 3 4 5 6 7 
 
95. Homosexuals should be barred from the teaching profession. 
 1 2 3 4 5 6 7  
 
      96. A man should never admit when others hurt his feelings. 
 1 2 3 4 5 6 7 
 
97. Men should get up to investigate if there is a strange noise in the house at night. 
 1 2 3 4 5 6 7 
  
98. A man shouldn't bother with sex unless he can achieve an orgasm. 
 1 2 3 4 5 6 7 
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Strongly Disagree Slightly No        Slightly Agree     Strongly 
Disagree   Disagree Opinion      Agree      Agree 
      1       2       3       4                  5                 6                7 
 
 
 
99. Men should be detached in emotionally charged situations. 
 1 2 3 4 5 6 7 
 
100. It is important for a man to take risks, even if he might get hurt. 
 1 2 3 4 5 6 7 
 
      101. A man should always be ready for sex. 
 1 2 3 4 5 6 7 
 
102. A man should always be the major provider in his family. 
 1 2 3 4 5 6 7 
 
103. When the going gets tough, men should get tough. 
 1 2 3 4 5 6 7 
 
      104. I might find it a little silly or embarrassing if a male friend of mine cried over a    
           sad love story. 
 1 2 3 4 5 6 7 
 
105. Fathers should teach their sons to mask fear. 
 1 2 3 4 5 6 7 
 
      106. I think a young man should try to be physically tough, even if he’s not big. 
 1 2 3 4 5 6 7  
 
      107. In a group, it is up to the men to get things organized and moving ahead. 
 1 2 3 4 5 6 7 
 
      108. One should not be able to tell how a man is feeling by looking at his face. 
 1 2 3 4 5 6 7 
 
      109. Men should make the final decision involving money. 
 1 2 3 4 5 6 7 
 
      110. It is disappointing to learn that a famous athlete is gay. 
 1 2 3 4 5 6 7 
 
      111. Men should not be too quick to tell others that they care about them. 
 1 2 3 4 5 6 7 
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112. How old are you in years? ______________. 
113. What is your school zip code? __________. 
114. What is your home zip code? ___________. 
115. What is your sex? 
  Male  Female 
116. What year are you in college?   
□ Freshman   
□ Sophomore   
□ Junior   
□ Senior 
□ Graduate 
□ Other (please specify): _______________________ 
117. What is your current relationship status? 
□ Married 
□ Single, but in a committed relationship 
□ Single and dating 
□ Not currently dating   
118. How do you describe your sexual orientation?  
□ I prefer to have sex with women 
 □ I prefer to have sex with men 
□ I prefer to have sex with men and women 
119. Have you ever had sexual intercourse?  
I would like to ask you some questions about yourself, your current and 
previous relationships. Please check your response on the line as appropriate. 
Please be honest. 
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□ Yes □ No (skip to #121) 
120. How old, in years, were you when you first had sexual intercourse? _______.  
121. Which one of the following groups describes your race? 
□ American Indian or Alaska Native 
 □ Asian 
  □ Hispanic or Latino  
□ Black or African American 
□ Native Hawaiian or Pacific Islander 
 □ White or Caucasian 
  □ Other 
 
 
Thank-you for participating in the Knowledge and Attitudes towards Human 
Papillomavirus (HPV) and HPV Vaccination Survey. 
 
If you would like to be entered into the drawing for a $25 gift card,  
please click on the link below.  
Your contact information will not be linked to your survey responses. 
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